Apparatus and methods for delivery, repositioning, and retrieval of transcatheter prosthetic valves

Description

BACKGROUND

Embodiments are described herein that relate to devices and methods for use in the delivery, deployment, repositioning and retrieval of transcatheter prosthetic heart valves.

Prosthetic heart valves can pose particular challenges for delivery and deployment within a heart. Valvular heart disease, and specifically, aortic and mitral valve disease is a significant health issue in the United States (US); annually approximately 90,000 valve replacements are conducted in the US. Traditional valve replacement surgery involving the orthotopic replacement of a heart valve, is considered an “open heart” surgical procedure. Briefly, the procedure necessitates surgical opening of the thorax, the initiation of extra-corporeal circulation with a heart-lung machine, stopping and opening the heart, excision and replacement of the diseased valve, and re-starting of the heart. While valve replacement surgery typically carries a 1-4% mortality risk in otherwise healthy persons, a significantly higher morbidity is associated to the procedure largely due to the necessity for extra-corporeal circulation. Further, open heart surgery is often poorly tolerated in elderly patients. Thus elimination of the extra-corporeal component of the procedure could result in reduction in morbidities and cost of valve replacement therapies could be significantly reduced.

While replacement of the aortic valve in a transcatheter manner is the subject of intense investigation, lesser attention has been focused on the mitral valve. This is in part reflective of the greater level of complexity associated to the native mitral valve apparatus, and thus, a greater level of difficulty with regards to inserting and anchoring the replacement prosthesis. Thus, a need exists for delivery devices and methods for transcatheter heart valve replacements. There is also a need for devices and methods for repositioning and/or retrieving deployed prosthetic heart valves.

SUMMARY

Apparatus and methods are described herein for use in the delivery and deployment of a prosthetic mitral valve into a heart. In some embodiments, an apparatus includes a catheter assembly, a valve holding tube and a handle assembly. The valve holding tube is releasably couplable to a proximal end portion of the catheter assembly and to a distal end portion of the handle assembly. The handle assembly includes a housing and a delivery rod. The delivery rod is configured to be actuated to move distally relative to the housing to move a prosthetic heart valve disposed within the valve holding tube out of the valve holding tube and distally within a lumen of the elongate sheath of the catheter assembly. The catheter assembly is configured to be actuated to move proximally relative to the housing such that the prosthetic valve is disposed outside of the lumen of the elongate sheath.

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1 is a cross-sectional illustration of portion of a heart with a prosthetic mitral valve implanted therein.

FIG. 2 is a schematic illustration of a delivery device, according to an embodiment.

FIG. 3 is a schematic illustration of a valve loading device, according to an embodiment.

FIG. 4 is a top view of a delivery device, according to an embodiment.

FIG. 5 is an exploded view of the delivery device of FIG. 4.

FIG. 6 is a side view of a handle assembly of the delivery device of FIG. 4.

FIG. 7 is a side cross-sectional view of the handle assembly of FIG. 6.

FIG. 8 is a side view of a catheter assembly of the delivery device of FIG. 4.

FIG. 9 is a side cross-sectional view of the catheter assembly of FIG. 8.

FIG. 10A is a perspective view of a valve holding tube of the delivery device of FIG. 4.

FIG. 10B is a side cross-sectional view of the valve holding tube of FIG. 10A.

FIG. 11 is a top view of the handle assembly of the delivery device of FIG. 4 illustrating the delivery rod actuated distally.

FIG. 12A is a top view of the delivery device of FIG. 4 shown with the delivery sheath in a first partially actuated position.

FIG. 12B is a top view of the delivery device of FIG. 4 shown with the delivery sheath in a second fully actuated position.

FIG. 13 is a perspective view of a delivery device, according to another embodiment.

FIG. 14 is a side view of a recapture device, according to an embodiment, and shown coupled to a frame of a prosthetic valve.

FIG. 15 is an enlarged view of a portion of the recapture device and prosthetic valve frame of FIG. 14 shown with the inner dilator member in a first position engaged with the prosthetic valve frame.

FIG. 16 is an enlarged view of a portion of the recapture device and prosthetic valve frame of FIG. 14 shown with the inner dilator (not visible) in a second position disposed within the outer dilator, and the outer sheath extended over a portion of the outer dilator and a portion of the valve captured within the outer sheath.

FIG. 17 is an enlarged view of a portion of the recapture device and prosthetic valve frame of FIG. 14 shown with the outer dilator (not visible) disposed within the outer sheath and a portion of the valve frame captured within the outer sheath.

FIG. 18 is a perspective view of a valve loading device, according to an embodiment.

FIG. 19 is an exploded view of the valve loading device of FIG. 18.

FIG. 20A is a top view of the valve loading device of FIG. 18.

FIG. 20B is a cross-sectional view of the valve loading device of FIG. 20A.

FIG. 21A is a side view of a handle assembly of the valve loading device of FIG. 18.

FIG. 21B is a cross-sectional view of the handle assembly of FIG. 21A.

FIG. 22A is a side view of a top cap assembly of the valve loading device of FIG. 18.

FIG. 22B is a side view of an outer funnel of the valve loading device of FIG. 18.

FIG. 23 is a cross-sectional view of the valve loading device of FIG. 18, shown in a first position prior to actuation of the loading device.

FIG. 24 is a cross-sectional view of the valve loading device of FIG. 18, shown in a second position after actuation of the loading device with the leadscrew extended from the handle assembly.

FIG. 25 is a perspective view of a valve loading device, according to another embodiment, shown with the loading leadscrew in an actuated position.

FIG. 26 is a flowchart illustrating a method of delivering a prosthetic heart valve according to an embodiment.

FIG. 27 is a schematic illustration of a kit according to an embodiment.

FIG. 28 is a side view of a dilator device according to an embodiment.

FIG. 29 is a cross-sectional view taken along line B-B in FIG. 28.

FIG. 30 is a side view of a balloon member of the dilator device of FIG. 28 in an expanded configuration.

FIG. 31 is a side view of the balloon member of the dilator device of FIG. 28 in a collapsed configuration.

FIG. 32 is an enlarged view of detail C in FIG. 30.

FIG. 33 is a distal end view of the balloon member of FIG. 30.

FIG. 34 is a cross-sectional view taken along the line D-D in FIG. 30.

FIG. 35 is a cross-sectional view taken along the line E-E in FIG. 30.

FIG. 36 is a side view of the balloon member, the elongate inflation tube, and the elongate guidewire tube of the dilator device of FIG. 28.

FIG. 37 is an enlarged view of detail F in FIG. 36.

FIG. 38 is a cross-section view taken along the line G-G in FIG. 37.

FIG. 39 is a side view of the balloon member and the elongate inflation tube of FIG. 28.

FIG. 40 is an enlarged view of detail H in FIG. 39.

FIG. 41 is a side view of a distal portion of the elongate inflation tube of FIG. 28.

FIG. 42 is a cross-sectional view of the elongate inflation tube of FIG. 41 taken along line I-I in FIG. 41.

FIG. 43 is a side view of a balloon member of a dilator device, according to another embodiment shown disposed partially within a delivery sheath.

FIG. 44 is a perspective view of a recapture device, according to another embodiment.

FIG. 45 is a side view of the recapture device of FIG. 44.

FIG. 46 is a side cross-sectional view of the recapture device of FIGS. 44 and 45.

FIG. 47 is a perspective view of a recapture device, according to another embodiment.

FIG. 48 is a side view of the recapture device of FIG. 47.

FIG. 49 is a side cross-sectional view of the recapture device of FIGS. 47 and 48.

FIG. 50 is a perspective view of a recapture device, according to another embodiment.

FIG. 51 is a side view of the recapture device of FIG. 50.

FIG. 52 is a side cross-sectional view of the recapture device of FIG. 50.

FIG. 53 is a perspective view of a recapture device, according to another embodiment.

FIG. 54 is a side cross-sectional view of the recapture device of FIG. 53

FIG. 55 is a top view of the recapture device of FIG. 53.

FIG. 56 is a cross-sectional view taken along line 56-56 in FIG. 55.

DETAILED DESCRIPTION

Apparatus and methods are described herein for use in the delivery and deployment of a prosthetic heart valve (e.g., a prosthetic mitral valve) into a heart. In some embodiments, a delivery device as described herein can be used to deploy and reposition a prosthetic heart valve. In some embodiments, a delivery device as described herein can include a two-stage controlled deployment mechanism for allowing accurate valve deployment. A delivery device as described herein can include a single 34Fr all-in-one system that can accommodate a variety of valve sizes. In some embodiments, a repositioning and retrieval device is described herein that can be used to reposition and/or retrieve a deployed prosthetic heart valve. The repositioning and retrieval device can include a two-stage controlled capture of a prosthetic valve implanted within a heart to reposition and/or remove/retrieve the prosthetic valve.

Although some embodiments are described herein with reference to a prosthetic mitral valve, it should be understood that the apparatus and methods described herein can be used to deploy, reposition and/or remove other any type of heart valve. For example, the apparatus and methods described herein can be used to deploy, reposition and/or remove a tricuspid heart valve, a pulmonary heart valve or an aortic heart valve. Further, the apparatus and methods described herein can be used from various delivery approaches to the heart, such as, for example, a transapical approach, transatrial, or a transventricular or transvascular approach (e.g., transjugular, transfemoral).

In some embodiments, a dilator device can be coupled to or incorporated within the delivery device. In some embodiments, the dilator device can include a balloon dilator member and be inserted through a port defined in, for example, the handle assembly or the catheter assembly of the delivery device. Such a dilator device is described below with reference to FIGS. 13 and 28-43. Use of a dilator device can help reduce the risk of damaging the prosthetic valve and/or the heart (e.g., the atrium).

As described herein, in some embodiments, a delivery device can include a handle assembly having one or more actuators, a delivery catheter assembly and a valve holding tube. The valve holding tube can be removably coupled to a distal end portion of the handle assembly and removably coupled to a hub of the delivery catheter assembly. In some embodiments, the valve holding tube can be coupled to the handle assembly, and the valve holding tube and handle assembly can be collectively and movably coupled to the delivery catheter. In some embodiments, the valve holding tube can be coupled to the catheter assembly prior to being coupled to the handle assembly. In some embodiments, during use, the valve holding tube is coupled to the handle assembly and to the catheter assembly prior to the catheter assembly being inserted into a heart. In some embodiments, the valve holding tube and handle assembly can be collectively and movably coupled to the delivery catheter assembly after the catheter assembly has been inserted into the heart. A dilator device is also described herein that can optionally be used during a procedure to deliver a prosthetic valve (e.g., prosthetic mitral valve) to the heart and can be received through a lumen of the delivery catheter. The delivery devices described herein can be used to deploy a prosthetic mitral valve into the heart in a controlled manner providing incremental movement of the prosthetic mitral valve within the delivery catheter and into the heart.

In some embodiments, an apparatus includes a catheter assembly, a valve holding tube and a handle assembly. The valve holding tube is releasably couplable to a proximal end portion of the catheter assembly and to a distal end portion of the handle assembly. The handle assembly includes a housing and a delivery rod. The delivery rod is configured to be actuated to move distally relative to the housing to move a prosthetic heart valve disposed within the valve holding tube out of the valve holding tube and distally within a lumen of the elongate sheath of the catheter assembly. The catheter assembly is configured to be actuated to move proximally relative to the housing such that the prosthetic valve is disposed outside of the lumen of the elongate sheath.

In some embodiments, an apparatus includes a loading funnel assembly configured to receive therein a prosthetic heart valve when the valve is in a non-collapsed or biased expanded configuration and a valve holding tube that defines an interior region that is configured to receive a prosthetic heart valve in a collapsed configuration. The valve holding tube has a first end portion configured to be releasably coupled to the loading funnel assembly and a second end portion. The apparatus further includes a handle assembly that includes a handle and a loading leadscrew. The loading leadscrew can be releasably coupled to the second end portion of the valve holding tube. The handle assembly further includes a tether retention mechanism and an actuator knob. The tether retention mechanism can secure a tether extending from a prosthetic heart valve disposed within the funnel assembly in a fixed position relative to the handle assembly. The actuator knob is operatively coupled to the loading leadscrew and the handle such that relative movement between the handle and the loading leadscrew causes the prosthetic valve to be disposed within the valve holding tube.

In some embodiments, an apparatus includes a recapture device that can be used to remove or reposition a prosthetic heart valve deployed within a heart. The recapture device includes an outer sheath, an outer dilator, an inner dilator, and a handle assembly. The outer sheath defines a first lumen and the outer dilator defines a second lumen and is movably disposed at least partially within the first lumen of the outer sheath. The inner dilator is movably disposed at least partially within the second lumen of the outer dilator and includes a distal tip. The handle assembly includes an actuator operatively coupled to the inner dilator and operatively coupled to the outer dilator and a tether retention mechanism to secure to the handle assembly a tether extending from the prosthetic heart valve. The actuator includes a drive mechanism operatively coupled to a first spring coupled to the inner dilator and to a second spring coupled to the outer dilator. When the actuator is actuated, the inner dilator moves proximally relative to the outer dilator when the tether extending from the prosthetic heart valve is secured to the tether retention mechanism such that a first portion of the prosthetic heart valve is pulled to within the second lumen of the outer dilator and moved to a collapsed configuration. The outer dilator can be actuated sequentially after the inner dilator to move the outer dilator proximally relative to the outer sheath such that a second portion of the prosthetic heart valve, distal of the first portion of the prosthetic heart valve, is pulled within the first lumen of the outer sheath and moved to a collapsed configuration.

In some embodiments, a method of delivering a transcatheter mitral valve replacement to the mitral annulus of a heart includes deploying into the mitral annulus a transcatheter mitral valve prosthesis using a delivery device as described herein. The transcatheter mitral valve prosthesis can be made from an expandable metal stent body having valve leaflets disposed therein. The stent body can be covered with a synthetic material or stabilized pericardial tissue and the valve leaflets can be made from stabilized pericardial tissue. The expandable metal stent body can have an optional atrial cuff and the cuff can optionally have a covering made from a synthetic material and/or stabilized pericardial tissue. The transcatheter mitral valve prosthesis can be deployed via catheter in a compressed state and expanded upon ejection from the catheter. The mitral valve prosthesis (also referred to herein as “prosthetic mitral valve” or “prosthetic valve” or “prosthetic heart valve”) may include one or more tethers coupled to a proximal end portion of the mitral valve prosthesis.

A distal end of the one or more tethers can be anchored, for example, in the left ventricle. The one or more tethers can be tightened and/or otherwise adjusted to a desired tension prior to fastening the one or more tethers to establish a fixed length and securing the tethers to, for example, an apex region of the heart. Prosthetic mitral valves that can be delivered with the devices and methods disclosed herein can include, for example, those disclosed in International Patent Application Serial Nos. PCT/US14/40188 entitled “Structural Members for Prosthetic Mitral Valves,” filed May 30, 2014 (“PCT application '40188”), PCT/US14/44047 entitled “Thrombus Management and Structural Compliance Features For Prosthetic Heart Valves,” filed Jun. 25, 2014 (“PCT application '44047”), PCT/US14/58826 entitled “Prosthetic Heart Valve and Systems and Methods for Delivering the Same,” filed Oct. 2, 2014 (“PCT application '58826”), and PCT/US16/12305 entitled Prosthetic Mitral Valves and Apparatus and Methods for Delivery of Same” filed Jan. 6, 2016 (“PCT application '12305”), the disclosures of which are incorporated herein by reference.

In some embodiments, a surgical kit can include a delivery device as described herein and accessory components that can be used with the delivery device in a procedure to deliver a transcatheter prosthetic valve as described herein. The delivery device and the accessory components can be disposed within a sterile package. For example, in some embodiments, a kit can include a delivery device and a dilator device and/or a valve loading device as described herein. In some embodiments, a kit can also include a transcatheter valve (e.g., a prosthetic mitral valve) and/or an epicardial pad that can be used to secure the transcatheter valve in position within the heart. In some embodiments, a kit can include a retrieval and repositioning device as described herein.

As used herein, the words “proximal” and “distal” refer to a direction closer to and away from, respectively, an operator of, for example, a medical device. Thus, for example, the end of the medical device closest to the patient's body (e.g., contacting the patient's body or disposed within the patient's body) would be the distal end of the medical device, while the end opposite the distal end and closest to, for example, the user (or hand of the user) of the medical device, would be the proximal end of the medical device.

FIG. 1 is a cross-sectional illustration of the left ventricle LV and left atrium LA of a heart having a transcatheter prosthetic mitral valve PMV deployed therein and an epicardial anchor device EAD securing the prosthetic mitral valve PMV to the apex region of the heart. FIG. 1 illustrates the prosthetic mitral valve PMV seated into the native valve annulus NA and held there using an atrial cuff AC of the prosthetic mitral valve PMV, the radial tension from the native leaflets, and a ventricular tether T secured with attachment portions Tp to the prosthetic mitral valve PMV and to the epicardial anchor EAD. The apparatus and methods described herein can be used in conjunction with the various different types and embodiments of an epicardial anchor device, such as those described in pending International Patent Application No. PCT/US14/49218 entitled “Epicardial Anchor Devices and Methods,” (“PCT application '49218”) the disclosure of which is incorporated herein by reference in its entirety.

FIG. 2 is a schematic illustration of a delivery device, according to an embodiment. A delivery device 100 can be used to deliver and deploy a prosthetic heart valve within the heart, such as, for example, a prosthetic mitral valve. The delivery device 100 includes a catheter assembly 130, a handle assembly 120 removably couplable to the catheter assembly 130, and a valve holding tube 125 removably couplable to the handle assembly 120 and to the catheter assembly 130.

The catheter assembly 130 includes a hub 132 and a delivery sheath 136. The delivery sheath 136 defines a lumen (not shown in FIG. 2) through which the valve holding tube 125 can be inserted to deliver a prosthetic valve (not shown in FIG. 2) disposed within the valve holding tube 125 as described in more detail below. In some embodiments, the delivery sheath 136 can be for example, a 34Fr braided sheath. The hub 132 is disposed at a proximal end of the sheath 136 and defines an interior region through which the prosthetic valve is first introduced prior to insertion into the lumen of the sheath 136. In use, the hub 132 remains outside the heart and can provide access to the lumen of the sheath when it is inserted into the heart. The hub 132 can also include a port (not shown in FIG. 2) through which a device, such as a dilator device, can be introduced as described in more detail below.

The handle assembly 120 includes a housing 122, a tether retention and mechanical retention coupler (also referred to herein as “retention mechanism”) 127 coupled to the housing 122, a delivery rod 124 extending distally from the housing 122, a proximal actuator knob 126 (also referred to as “proximal actuator” or “first actuator”) coupled to the housing 122, and a distal actuator knob 128 (also referred to as “distal actuator” or “second actuator”) coupled to the housing. The proximal actuator knob 126 can be operatively coupled to the delivery rod 124 and used to move or push distally within the delivery sheath 136, a prosthetic heart valve that is pre-loaded into the valve holding tube 125 and coupled to the handle assembly 120 as described in more detail below. The distal actuator knob 128 can be operatively coupled to the delivery sheath 136 and used to actuate or move the delivery sheath 136 during deployment of the prosthetic valve into the heart. For example, the prosthetic valve can first be moved distally by the delivery rod 124 until it is positioned within a distal end portion of the delivery sheath 136, and then to deploy the prosthetic valve within the heart, the delivery sheath 136 is moved proximally, disposing the prosthetic valve outside of the delivery sheath 136 and within the heart. The distal actuator 128 can provide a slow, controlled deployment of the prosthetic valve. In some embodiments, the delivery sheath 136 can also be actuated to recapture a prosthetic heart valve that has already been deployed within a heart such that the prosthetic valve can be repositioned or removed. For example, upon initial deployment of the valve within the heart, it may be desirable to reposition the valve. The delivery device 100 can be actuated to partially recapture a proximal portion of the valve to make adjustments to its position. For example, the delivery sheath can be actuated to move distally to recapture a portion of the valve, then after the valve has been repositioned, the sheath can be actuated to move proximally again to release the valve. The delivery rod 124 can also be used to recapture a portion of the prosthetic valve. For example, the delivery rod 124 can define a lumen and can be actuated to move distally such that a portion of the prosthetic valve is recaptured within the lumen of the delivery rod 124. Further details of the delivery and deployment of a prosthetic heart valve using the delivery device are provided below with reference to specific embodiments.

The valve holding tube 125 can contain or hold a prosthetic mitral valve (not shown in FIG. 2) in a compressed configuration within an interior lumen of the valve holding tube 125. As discussed with respect to FIG. 3, in some embodiments, a valve loading device 160 can be used to load the prosthetic valve into the valve holding tube 125 such that the prosthetic valve is compressed in a controlled manner to a desired compressed size and shape. Such a valve loading device is also described in more detail below with reference to a specific embodiment (see, e.g., FIGS. 18-24). The valve holding tube 125 (with the prosthetic mitral valve therein) can be coupled to a distal end portion of the handle assembly 120. For example, the valve holding tube 125 can be coupled to the handle assembly 120 such that a portion of the distal end portion of the delivery rod 124 of the handle assembly 120 can be received within an interior region of the valve holding tube 125. In some embodiments, the valve holding tube 125 and the handle assembly 120 can include mating quick connect couplers to releasably couple the valve holding tube 125 to the handle assembly 120. Prior to coupling the valve holding tube 125 to the delivery device 220, a tether (not shown) coupled to the prosthetic valve (within the valve holding tube 125) can be threaded through a lumen defined by the delivery rod 124 and extend proximally out of the handle assembly 120.

The valve holding tube 125 can have various lengths to accommodate various different procedures to deliver the prosthetic heart valve to the heart. For example, in some embodiments, the valve holding tube 125 can have a length of between about 2 cm and 15 cm. In some embodiments, the sheath 136 can have a length of about 12 cm to about 38 cm. In some embodiments, the sheath 136 can have a length of about 50 cm to about 150 cm.

In some embodiments, the prosthetic heart valve (e.g., mitral valve) can be delivered apically, i.e. delivered through the apex of the left ventricle of the heart, using the delivery device 100 described herein. With such apical delivery, the delivery device 100 can access the heart and pericardial space by intercostal delivery. In this case, the sheath 136 can have a length of, for example, 12-38 cm.

In another delivery approach, the delivery device 100 can deliver the prosthetic heart valve using either an antegrade or retrograde delivery approach without requiring the use of a rigid tube system that is commonly used in such procedures. In another embodiment, the delivery device 100 can access the heart via a trans-septal approach. In either case, where a long distance must be travelled, the valve holding tube 125 can have a length of, for example, 60-150 cm.

The tether retention mechanism 127 can be coupled to a proximal end portion of the housing 122 and can be used to couple a tether(s) extending from a prosthetic valve to the handle assembly 120. One or more tethers coupled to the prosthetic valve can extend through the handle assembly 120 and can also be inserted or threaded through the retention mechanism 127. In some embodiments, the retention mechanism 127 includes a spring mechanism that can be used to secure the tether to the tether retention mechanism 127 and thus to the handle assembly 122. The spring mechanism can be actuated to deflect the tether (e.g., bend Nitinol wire of tether) and apply a constant or substantially constant force (e.g., tension) on the tether during deployment. The spring mechanism can also allow for adjustment of the force applied to the prosthetic valve during removal of the delivery device after deployment of a prosthetic valve. The tension on the tether can be released to allow movement of the prosthetic valve, and then re-tensioned to secure the tether and prosthetic valve in the new position. In some embodiments, the tether retention mechanism 127 includes a tether pinning mechanism. In such an embodiment, a pinning member can be used to pierce the tether to secure the tether to the retention mechanism 127.

The tether retention mechanism 127 can provide additional safety during a deployment procedure in that, with a compressed valve under great pressure, release from a catheter can launch the prosthetic valve, for example, a distance of many feet. However, with the retention mechanism 127 provided herein and the ability to provide a slow calibrated deployment, the user can control the deployment to prevent the valve from inadvertently being projected from the sheath 136.

In one example use to deliver and deploy the prosthetic mitral valve within a heart, the sheath 136 of the catheter assembly 130 can be inserted through the epicardial surface of the patient's heart and extended through the left ventricle and to the left atrium of the heart such that the hub 132 is disposed on the outside of the heart near or in contact with the epicardial surface. In some embodiments, prior to introducing the sheath 136 into the heart, a guidewire (not shown) is extended into the heart and to the left atrium. The sheath 136 can then be threaded over the guidewire to be inserted into the heart. For example, the guidewire can be extended through the sheath 136 and out a port disposed on the hub 132. In some embodiments, prior to inserting the sheath 136 into the heart, a dilator device (not shown in FIG. 2) can be inserted through the port of the hub 132 and through the lumen of the sheath 136, such that a tapered distal end portion of the dilator device extends outside a distal end of the sheath 136. The tapered distal end of the dilator device can provide a lead-in for the sheath 136 and help open or enlarge the entry opening at the epicardial surface and through the mitral annulus. An example dilator device is described in U.S. patent application Ser. No. 14/527,382, filed Oct. 29, 2014 (“the '382 application”), the entire disclosure of which is incorporated herein by reference. Other embodiments of a dilator device are described herein with reference to FIGS. 13 and 28-43. When the sheath 136 is placed at the desired position within the heart, the dilator device can be removed leaving the sheath 136 within the heart. Further details of a dilator device are described below.

As described above, the valve holding tube 125 (with a prosthetic valve disposed therein) can be coupled to a distal end portion of the handle assembly 120. The tether extending from the valve can be threaded through the delivery rod 124 and extend out a proximal end of the handle assembly 120. With the valve holding tube 125 coupled to the distal end portion of the handle assembly 120, and the distal end portion of the delivery rod 124 disposed within the valve holding tube 125, the valve holding tube 125 can be inserted into the hub 132 of the catheter assembly 130 and coupled to the hub 132. In some embodiments, O-rings (not shown in FIG. 1) on the valve holding tube 125 can maintain the position of the valve holding tube 125 within the hub 132. For example, in some embodiments, the valve holding tube 125 and the hub 132 can include mating quick connect couplers that include O-rings, to releasably couple the valve holding tube 125 to the hub 132.

With the valve holding tube 125 coupled to the catheter assembly, the proximal actuator knob 126 can then be actuated (e.g., rotated) to move the delivery rod 124 distally such that a distal end of the delivery rod 124 pushes the prosthetic valve out of the valve holding tube 125 and into a distal end portion of the delivery sheath 136. As the delivery rod 124 moves distally, the delivery rod 124 moves relative to the housing 122 of the handle assembly 120, and the valve holding tube 125 remains stationary relative to the housing 122, allowing the delivery rod 124 to push the prosthetic valve out of the valve holding tube 125 and into the delivery sheath 136. The tether can then be secured to the retention mechanism 127, securing the valve to the housing 122. The distal actuator knob 128 can then be actuated to retract or move proximally the delivery sheath 136 (and the valve holding tube 125 coupled thereto via the hub 132) relative to the housing 122 such that the prosthetic valve is left disposed outside of the delivery sheath 136 and within the left atrium of the heart or within the annulus of the native mitral valve. After the prosthetic valve has been deployed, the prosthetic valve can be maneuvered and repositioned as needed and then the tether can be released from the retention mechanism 127. The tether can then be secured to an epicardial surface of the heart with, for example, an epicardial pad (e.g., EAD in FIG. 1) as described above.

In an alternative example procedure, rather than first inserting the catheter assembly 130 into the heart, and then coupling the valve holding tube 125 and handle assembly 120 thereto, the valve holding tube 125 can be coupled to both the handle assembly 120 and to the catheter assembly 130 prior to the catheter assembly 130 being inserted into the heart. In such a procedure, the same steps described above can be employed for inserting the catheter assembly 130 into the heart, such as, for example, inserting the catheter assembly 130 over a guidewire and/or using a dilator device as described above. The delivery device 100 can then be actuated in the same manner as described above to first move the prosthetic valve distally within the delivery sheath 136 and then move the delivery sheath 136 proximally to dispose the prosthetic valve in the heart.

FIG. 3 is a schematic illustration of a valve loading device 160. The valve loading device 160 includes a funnel assembly 115, a loading handle assembly 165 and the valve holding tube 125 described above. Prior to coupling the valve holding tube 125 to the handle assembly 120 and catheter assembly 130, a prosthetic valve (also referred to herein as “valve”) is loaded into the valve holding tube 125 using the valve loading device 160. The valve is first placed within the funnel assembly 115 to move the valve from a biased expanded configuration to a collapsed configuration. The funnel assembly 115 includes an outer funnel 164 and an inner funnel or centering cone 162. The valve is placed within the outer funnel 164 and then the inner funnel is coupled to the outer funnel 164 sandwiching the valve therebetween and collapsing the valve to a desired shape and configuration in a controlled manner. The valve holding tube 125 can be releasably coupled to the funnel assembly 115 and to the loading handle assembly 165 via quick connect couplers in a similar manner as how the valve holding tube 125 is coupled to the handle assembly 120 and catheter assembly 130 described above.

The loading handle assembly 165 includes a handle 157 (also referred to as “main loading knob” or “actuator”), a retention mechanism 168 for securing a tether coupled to the valve, and a loading leadscrew 166 operatively coupled to the handle 157. With the valve holding tube 125 coupled to the funnel assembly 115 and to the loading handle assembly 165, and with the tether extending from the valve secured to the retention mechanism 168, the valve loading device 160 can be actuated to move the valve from a first position in which it is disposed within the funnel assembly to a second position in which the valve is disposed within the valve holding tube 125. More specifically, the handle 167 can be rotated, which in turn moves the leadscrew relative to the handle 167, which in turn moves the valve holding tube 125 and funnel assembly 115 away from the handle 167. Because the valve is in a fixed position (i.e., is stationary) relative to the handle 167 during actuation (through the securement of the tether to the retention mechanism 168), the funnel assembly 115 is moved away from the handle, and the valve holding tube 125 is moved over the valve, disposing the valve within an interior region of the valve holding tube 125. Details regarding the various components and operation of the valve loading device 160 are described below with respect to FIGS. 18-25 and valve loading device 560.

FIGS. 4-12 illustrate a delivery device according to one embodiment. A delivery device 200 includes a catheter assembly 230, a handle assembly 220 removably couplable to the catheter assembly 230 and a valve holding tube 225 removably couplable to the handle assembly 220 and the catheter assembly 230. The delivery device 200 can include the same or similar components and features, and can function the same as or similar to the delivery device 100 described above. The delivery device 200 can be used to deliver and deploy a prosthetic heart valve within the heart, such as, for example, a prosthetic mitral valve (not shown) as described above for the previous embodiment.

The catheter assembly 230 includes a hub 232 and a delivery sheath 236. The delivery sheath 236 defines a lumen 221 (FIG. 9) into which a prosthetic valve (not shown) pre-disposed within an interior region of the valve holding tube 225 can be moved during delivery of the prosthetic valve. The hub 232 is disposed at a proximal end of the sheath 236 and defines an interior region through which the prosthetic valve is first introduced prior to insertion into the lumen of the sheath 236. In use, the hub 232 remains outside the heart and can provide access to the lumen of the sheath 236 when it is inserted into the heart. The hub 232 also includes a port 237 through which, various devices, such as for example, a dilator device (not shown) can be inserted and used during the delivery of a prosthetic heart valve as described in more detail with respect to the embodiment of FIG. 13. Other embodiments of a dilator device are described below with respect to FIGS. 28-43, which can be used with the delivery device 200. The port 237 can also be used to receive a guidewire therethrough. For example, a guidewire can be threaded through a distal end of the delivery sheath 236, into the interior of the hub 232, and out through the port 237.

The handle assembly 220 includes a housing 222, a tether retention mechanism 227 coupled to the housing 222, a delivery rod 224 coupled to the housing 222, a proximal actuator knob 226 (also referred to as “first actuator” or “proximal actuator”) coupled to the housing 222, and a distal actuator knob 228 (also referred to as “second actuator” or “distal actuator”) coupled to the housing 222. A deployment travel window 223 is disposed on the housing 222 and can be used to view the progress of the delivery of the prosthetic valve. For example, the delivery rod 224 can include markings that are visible through the deployment travel window. The markings can be, for example, labeled with numbers or letters, or can be color coded. The markings can indicate the progress or distance the valve has traveled distally during deployment of the valve. Markings can also be included that indicate the movement proximally of the delivery sheath during deployment of the valve.

The proximal actuator knob 226 can be used to move or push distally within the delivery sheath 236, a prosthetic heart valve (not shown) that is pre-loaded into the valve holding tube 225 and coupled to the handle assembly 220. For example, the proximal actuator knob 226 can be operatively coupled to the delivery rod 224 and can be used to move the delivery rod 224 distally within the delivery sheath 236 relative to the housing 222 such that the delivery rod 224 engages the prosthetic heart valve and moves (e.g., pushes) the prosthetic heart valve distally within the delivery sheath 236 until the prosthetic heart valve is disposed within a distal end portion of the delivery sheath 236. In this embodiment, the proximal actuator 226 is rotated, which in turn causes the rod 224 to move relative to the housing 222. When deploying a valve, the valve holding tube 225 is secured in a fixed relation to the housing 222, and thus, does not move relative to the housing 222 when the rod 224 is actuated. This allows the rod 224 to push the valve distally out of the valve holding tube 225 and into the hub 232 and then within a distal end portion of the delivery sheath 236. With the valve disposed within a distal end of the delivery sheath 236, the tether can be secured to the housing 222 via the retention mechanism 227.

The distal actuator knob 228 can be operatively coupled to the delivery sheath 236 and used to actuate or move the delivery sheath 236 during deployment of the prosthetic valve into the heart. In this embodiment, as shown in FIG. 7, the distal actuator knob 228 is coupled to a leadscrew 229, which in turn is coupled to the valve holding tube 225. Thus, when the valve holding tube 225 is coupled to the hub 232, the leadscrew 229 can be actuated to move the valve holding tube 225 and the catheter assembly 230 relative to the housing. For example, as described above, with the prosthetic valve disposed within the delivery sheath 236, to deploy the prosthetic valve into the heart, the delivery sheath 236 is moved proximally relative to the housing 222 (by actuating the distal actuator knob 228) disposing the prosthetic valve outside of the delivery sheath 236 and within the heart.

The delivery sheath 236 can also be actuated to partially recapture a prosthetic heart valve that has already been deployed within a heart such that the prosthetic valve can be repositioned. For example, after the prosthetic valve has been deployed as described above, if it is determined that the prosthetic valve should be repositioned, the actuator knob 228 can be actuated in an opposite direction to move the leadscrew 229 distally, causing the delivery sheath 236 to move distally back over a proximal portion of the prosthetic valve. The delivery device 200 can then be maneuvered to position the prosthetic valve in a desired location, and then the actuator knob 228 can be actuated to move the delivery sheath 236 proximally, again releasing the prosthetic valve from the delivery sheath 236. Further, as described previously, the delivery rod 224 can be actuated by the actuator knob 226 to move distally to recapture a portion of the prosthetic valve within the lumen of the delivery rod 224.

As described above for the previous embodiment, the valve holding tube 225 (see, e.g., FIGS. 10A and 10B) can contain or hold a prosthetic mitral valve (not shown) in a compressed configuration within an interior lumen of the valve holding tube 225. As described above for FIG. 3, and described below with respect to FIGS. 18-25, a valve loading device can be used to pre-load the prosthetic valve into the valve holding tube 225 such that the prosthetic valve is compressed in a controlled manner to a desired compressed size and shape. The valve holding tube 225 (with the prosthetic mitral valve therein) can be removably coupled to a distal end portion of the handle assembly 220 and removably coupled to the hub 232 of the catheter assembly 230.

For example, as shown, for example, in FIG. 5, the valve holding tube 225 can include a first quick connect coupler 211 (a female connector in this embodiment) and a second quick connect coupler 212 (a male connector in this embodiment). The first quick connector 211 can be matingly coupled to a quick connect coupler 213 (a male connector in this embodiment) disposed at the distal end portion of the handle assembly 220. Similarly, the second quick connect coupler 212 of the valve holding tube 225 can be matingly coupled to a quick connect coupler 214 (a female connector in this embodiment) disposed on the hub 232 of the catheter assembly 230. The quick connect couplers can include O-rings to maintain the position of the valve holding tube 225 to the handle assembly 220 and to the catheter assembly 230. The quick connect couplers can be a variety of different types of suitable couplers/connectors. For example, the quick connect couplers can be a bayonet connector or ¼ turn connector. It should be understood that in alternative embodiments, the male and female couplers can be reversed (e.g., coupler 211 of valve holding tube 225 can be a male coupler that can be matingly coupled to a female coupler 213 of the handle assembly). With the valve holding tube 225 coupled to the handle assembly, a distal end portion of the delivery rod 224 of the handle assembly 220 can be received within an interior region of the valve holding tube 225. Prior to coupling the valve holding tube 225 to the delivery rod 224, a tether (not shown) coupled to the prosthetic valve (within the valve holding tube 225) can be threaded through a lumen defined by the delivery rod 224 and extend proximally out of the handle assembly 220.

The valve holding tube 225 can be configured the same as or similar to, and function the same as or similar to the valve holding tube 125 described above. For example, the valve holding tube 225 can have various lengths to accommodate various different procedures to deliver the prosthetic heart valve to the heart. The retention mechanism 227 can be coupled to a proximal end portion of the housing 222. In this embodiment, the retention mechanism 227 includes a tether pinning member that can be configured to pierce through the tether and secure the tether to the retention mechanism 227.

In use to deliver and deploy a prosthetic mitral valve within a heart, the valve holding tube 225 can be coupled to the handle assembly 220 and to the catheter assembly 230 via the quick connect couplers described above. For example, the valve holding tube 225 can be inserted into the hub 232 of the catheter assembly 230 and the quick connect couplers 212 and 214 can maintain the position of the valve holding tube 225 within the hub 232. Similarly, the quick connect couplers 211 and 213 can maintain the position of the valve holding tube 225 relative to the handle assembly 220. The delivery sheath 236 of the catheter assembly 230 can be inserted through the epicardial surface of the patient's heart and extended through the left ventricle and to the left atrium of the heart such that the hub 232 is disposed on the outside of the heart near or in contact with the epicardial surface. As described above, in some embodiments, prior to introducing the sheath 236 into the heart, a guidewire is extended into the heart and to the left atrium. The sheath 236 can then be threaded over the guidewire to be inserted into the heart. In some embodiments, prior to inserting the sheath 236 into the heart, a dilator device (not shown) (see, e.g., dilator device 354 in FIG. 13, and dilator devices 834 and 934 described below) can be used as described above to provide a tapered distal insertion tip for insertion of the delivery device 200 into the heart of a patient. As described above for delivery device 100, in an alternative procedure, the catheter assembly 230 can first be inserted into the heart, prior to the valve holding tube 225 being coupled thereto.

FIG. 4 illustrates the assembled delivery device 200 in a ready to use position (e.g., the valve holding tube 225 is coupled to the housing 222 and catheter assembly 230 with a prosthetic valve loaded therein). The proximal actuator knob 226 can then be actuated (e.g., rotated) to move the delivery rod 224 distally (in the direction of Arrow A in FIGS. 4 and 11) and push the prosthetic valve out of the valve holding tube 225 and into a distal end portion of the delivery sheath 236, as described above. FIG. 11 illustrates the delivery handle 220 without the catheter assembly 230 and valve holding tube 225 for illustrative purposes to show the delivery rod 224 actuated distally to push the prosthetic valve out of the valve holding tube 225. As the delivery rod 224 moves distally, the valve holding tube 225 remains stationary or fixed relative to the housing 222, allowing the delivery rod 224 to push the prosthetic valve out of the valve holding tube 225 and into the delivery sheath 236 until the valve holding tube 225 is disposed at a distal end portion of the delivery sheath 236. The tether can be secured to the retention mechanism 227, and the distal actuator knob 228 can then be actuated to retract or move proximally the delivery sheath 236 relative to the housing 222 such that the prosthetic valve is left disposed outside of the delivery sheath 236 and within the left atrium of the heart. More specifically, as described above, the distal actuator 228 is operatively coupled to the leadscrew 229, which is coupled to the valve holding tube 225. Thus, because the valve holding tube 225 is also coupled to the delivery sheath 236, the delivery sheath 236 is also moved proximally (the direction of arrow B in FIGS. 12A and 12B) relative to the housing 222. FIG. 12A illustrates the delivery sheath 236 partially retracted (moved proximally), and the valve holding tube 225 coupled thereto is shown partially disposed within the housing 222. FIG. 12B illustrates the delivery sheath 236 fully retracted, the hub 232 partially disposed within the housing 222, and the valve holding tube 225 disposed entirely within the housing 222. After the prosthetic valve has been deployed, with the tether coupled to the retention mechanism 227, the prosthetic valve can be maneuvered and repositioned as needed and then the tether can be released from the retention mechanism 227. The tether can then be secured to an epicardial surface of the heart with, for example, an epicardial pad (e.g., EAD in FIG. 1) as described above.

Further, prior to securing the tether, as described above, if upon initial deployment of the prosthetic valve it is determined that the valve should be repositioned, the delivery device 200 can be actuated to partially recapture a proximal portion of the valve to make adjustments to its position. For example, the delivery sheath 236 can be actuated to move distally to recapture a portion of the valve, then after the valve has been repositioned, the sheath 236 can be actuated to move proximally again to release the valve. Alternatively, the delivery rod 224 can also be used to recapture a portion of the prosthetic valve. For example, the delivery rod 224 can be actuated to move distally such that a portion of the prosthetic valve is recaptured within the lumen of the delivery rod 224. The valve can then be repositioned and then the delivery rod 224 can be actuated to move proximally to release the valve.

FIG. 13 illustrates a delivery device according to another embodiment. A delivery device 300 includes a catheter assembly 330, a handle assembly 320 removably couplable to the catheter assembly 330 and a valve holding tube (not shown) removably couplable to the handle assembly 320 and the catheter assembly 330. In this embodiment, the valve holding tube is disposed within an interior of a housing 322 of the handle assembly 320 and the catheter assembly 330. The delivery device 300 can include the same or similar components and features, and can function the same as or similar to the delivery device 100 and/or the delivery device 200 described above. The delivery device 300 can be used to deliver and deploy a prosthetic heart valve within the heart, such as, for example, a prosthetic mitral valve (not shown) as described above for the previous embodiment.

The catheter assembly 330 includes a hub 332 and a delivery sheath 336. The delivery sheath 336 defines a lumen (not shown) into which a prosthetic valve disposed within the valve holding tube can be moved during delivery of the prosthetic valve as described above for previous embodiments.

The handle assembly 320 includes the housing 322, a delivery rod (not shown) coupled to the housing 322, a proximal actuator knob 326 coupled to the housing 322, and a distal actuator knob 328 coupled to the housing 322. A deployment travel window 323 is disposed on the housing 322 and can be used to view the progress of the delivery of a prosthetic heart valve visible through the deployment travel window 323. The proximal actuator knob 326 can be used to move or push distally the prosthetic heart valve (not shown) that is loaded into the handle assembly 320 via the valve holding tube (not shown). The distal actuator knob 328 can be used to actuate or move the delivery sheath 336 during deployment of the prosthetic valve into the heart. For example, the prosthetic valve can be moved distally until it is positioned within a distal end portion of the lumen of the delivery sheath 336. To deploy the prosthetic valve, the delivery sheath 336 is moved proximally disposing the prosthetic valve outside of the delivery sheath 336 and within the heart. The delivery sheath 336 can also be actuated to recapture a prosthetic heart valve that has been deployed within a heart such that the prosthetic valve can be repositioned as described above for delivery devices 100 and 200. Although not shown in FIGS. 7 and 8, the housing 322 can also include a spring tether retention and mechanical retention coupler (also referred to herein as “retention mechanism”) coupled to the housing 322 as described above for previous embodiments.

As described above, the valve holding tube can contain or hold a prosthetic mitral valve in a compressed configuration within an interior lumen of the valve holding tube. The valve holding tube (with the prosthetic mitral valve therein) can be coupled to a distal end portion of the handle assembly 320 and coupled to the hub 332 of the catheter assembly 330. As described above for previous embodiments, when coupled to the handle assembly 320, a portion of the distal end portion of the delivery rod can be received within an interior region of the valve holding tube. Prior to coupling the valve holding tube to the delivery rod, a tether (not shown) coupled to the prosthetic valve (within the valve holding tube) can be threaded through a lumen defined by the delivery rod and extend proximally out of the handle assembly 320.

In this embodiment, a dilator device 354 is illustrated that can be used with the delivery device 300 during deployment of a prosthetic valve. The dilator device 354 can include a tapered distal end that can provide a lead-in for the sheath 336 and help open or enlarge the entry opening at the epicardial surface and through the mitral annulus. The dilator device 354 includes an expandable dilator balloon member 334 (also referred to herein as “balloon member”). The balloon member 334 is coupled to a balloon manifold 356 via an elongate inflation tube that extends through the delivery sheath 336 and out through a port 337 defined by the hub 332. The balloon member 334 has a tapered distal tip portion to provide a lead-in during insertion of the catheter assembly 330 into the heart. The balloon manifold 356 can be coupled to an inflation medium and used to inflate and deflate the balloon member 334. The port 337 is disposed on the hub 332 distally of the prosthetic valve. In other words, when the valve holding tube (containing the prosthetic valve) is coupled to the catheter assembly 330, the prosthetic valve is disposed proximally of where the balloon shaft exits the port 337. FIG. 13 also illustrates a shipping mandrel 353 that can be inserted through a lumen of the dilator device 354 and includes an elongate member 349. The elongate member 349 can be inserted through the balloon manifold 356, through a lumen defined by the dilator device 354, until a distal end is disposed outside a distal end of the balloon member 334. The shipping mandrel 353 can be used to maintain the alignment of the various components of the dilator device 354 and reduce or eliminate the possibility of components collapsing prior to use of the dilator device 354. The shipping mandrel 353 can be removed prior to insertion of the delivery device 300 into a patient's body.

In use to deliver and deploy a prosthetic mitral valve within a heart, with the dilator device 354, catheter assembly 330, handle assembly 320 and valve holding tube (not shown) coupled together, and with the balloon member 334 inflated, the delivery sheath 336 can be inserted through the epicardial surface of the patient's heart and extended through the left ventricle and into the left atrium of the heart such that the hub 332 is disposed on the outside of the heart near or in contact with the epicardial surface. When the delivery sheath 336 is positioned in a desired location, the balloon member 334 can be deflated and removed through the port 337.

The proximal actuator knob 326 can then be actuated (e.g., rotated) to move the delivery rod distally and push the prosthetic valve out of the valve holding tube and into a distal end portion of the delivery sheath 336 in a similar manner as described above for previous embodiments. The distal actuator knob 328 can then be actuated to retract or move proximally the delivery sheath 336 such that the prosthetic valve is left disposed outside of the delivery sheath 336 and within the left atrium of the heart.

FIGS. 14-17 illustrate a recapture device according to an embodiment. A recapture device 410 can be used to capture a prosthetic valve that is deployed within a heart such that the prosthetic valve can be repositioned and/or retrieved/removed. The recapture device 410 includes an outer sheath 444 operatively coupled to a handle assembly 420, an outer dilator 442 disposed within a lumen of the outer sheath 444, and an inner dilator 446 movably disposed within a lumen of the outer dilator 442 and operatively coupled to the handle assembly 420. The recapture device 410 also includes a tether retention mechanism 427 coupled to a proximal end portion of the handle assembly 420. The tether retention mechanism 427 can be configured the same as or similar to the retention mechanisms described herein and/or described in the '382 application incorporated herein by reference above, and can be used to secure the tether to the recapture device 410. The inner dilator 446 defines a lumen that can receive at least a portion of a prosthetic valve 440 and includes a distal tip configured to engage a prosthetic valve implanted within a heart as described in more detail below.

The handle assembly 420 includes a housing 422, a proximal actuator knob 426 coupled to the housing 422 and operatively coupled to the sheath 444, and a distal actuator knob 428 coupled to the housing 422 and operatively coupled to the dilator member 446. A deployment travel window 423 is disposed on the housing 422 and can be used to view the progress of the removal or recapture of a prosthetic heart valve. The proximal actuator knob 426 (also referred to herein as “proximal actuator” or “first actuator”) can be used to move the inner dilator 446 distally and proximally within the lumen of the outer dilator 442. The distal actuator knob 428 (also referred to herein as “distal actuator” or “second actuator”) can be used to actuate or move the outer sheath 444 distally and proximally.

As shown in FIGS. 14 and 15, to capture a prosthetic valve 440 that has been deployed within a heart, the tether coupled to the prosthetic valve 440 can be threaded or inserted through the lumen of the inner dilator 446 and the distal tip of the inner dilator 446 can engage a proximal portion of the valve 440 by actuating the proximal actuator 426 to move the inner dilator 446 distally into contact with the valve 440. Thus, as the inner dilator 446 is moved distally, a portion of the valve 440 can be received and collapsed within the lumen of the inner dilator 446, as shown in FIGS. 14 and 15. As shown in FIG. 16, the inner dilator 446 can be actuated (e.g., turning or rotating the proximal actuator knob 426) to move the inner dilator 446 proximally such that the distal tip of the dilator member 442 and a first portion of the valve 440 are pulled into the lumen of the outer dilator 442. For example, with the portion of the valve 440 collapsed within the lumen of the inner dilator, the valve 440 will move distally with the inner dilator 446. With the valve 440 captured as shown in FIG. 16, the tether can be secured to the retention mechanism 427, and the valve 440 can be moved/repositioned within the heart.

To fully remove/retrieve the valve 440, the sheath 444 can be moved distally as shown in FIG. 17, to further capture the valve 440 within the lumen of the sheath 444 until the valve 440 is fully captured within the lumen of the outer sheath 444. For example, the distal actuator knob 428 can be actuated (e.g., rotated or turned) to move the outer sheath 444 distally relative to the inner dilator 446 and to the outer dilator 442. The outer sheath 444 also moves relative to the handle assembly 422. Thus, with the tether secured to the handle assembly 422 via the retention mechanism 427, the outer sheath 444 moves distally relative to the valve 440 to capture the valve 440 within the lumen of the outer sheath 444. With the valve 440 captured within the lumen of the sheath 444, the valve 440 can be removed from the heart by removing the recapture device 410 from the heart and the patient's body.

The two-stage actuation of the recapture device 410 allows for a controlled capture of a prosthetic valve implanted within a heart to reposition and/or remove/retrieve the prosthetic valve. The proximal portion of the frame of the valve 440 can first be collapsed sufficiently for a portion of the frame to be disposed within the lumen of the outer dilator 442, and then can transition into a more fully collapsed configuration as it is moved into the lumen of the outer sheath 444. Further embodiments of a recapture device are described below with reference to FIGS. 44-53.

FIGS. 18-25 illustrate a valve loading device 560 according to an embodiment. The valve loading device 560 can be used to load a prosthetic valve (not shown) into a valve holding tube 525 which can be similar to or the same as the valve holding tubes described herein (e.g., 125, 225). The valve loading device 560 can be used to compress the prosthetic valve to a desired size and shape prior to loading the valve into the valve holding tube. Another embodiment of a valve loading device is described in the '382 application incorporated herein by reference above. The valve loading device 560 includes a handle assembly 565 and a funnel assembly 515 that includes a top cap assembly 596 and an outer funnel 564. The top cap assembly 596 includes an inner funnel or centering cone 562. As best shown in FIGS. 20B and 21B, the handle assembly 565 includes a centering rod 561 operatively coupled to a centering rod locator 563, a loading leadscrew 566 and a main loading knob or handle 567. A tether piercing member 568 can be used to secure a tether extending from the prosthetic valve within the valve loading device 560. The loading leadscrew 566 can be actuated to move the valve holding tube 525 and capture the prosthetic valve as described in more detail below.

The valve holding tube 525 can be removably coupled to the handle assembly 565 via a quick connect coupler 550 (a female connector in this embodiment) that can matingly couple to a quick connect coupler 551 (a male connector in this embodiment) on the loading leadscrew 566 of the handle assembly 565. The valve holding tube 525 can also be coupled to the outer funnel 564 via a quick connect coupler 541 (a male connector in this embodiment) that can matingly couple to a quick connect coupler 543 (a female connector in this embodiment) on the outer funnel 564. The quick connect couplers 550, 551, 541 and 543 can be, for example, bayonet connectors or ¼ turn connectors. The quick connect couplers can also include O-rings to maintain the position of the valve holding tube 525 to the handle assembly 565 and to the outer funnel 564. The centering rod 561 can be used to center the prosthetic valve and hold the valve in position when the valve is loaded within the outer funnel 564. A centering rod securement knob 569 secures the centering rod 561 in position. The centering rod securement knob 569 can be, for example, a thumb screw or set screw.

In some embodiments, prior to loading the prosthetic valve into the valve loading device 560, the handle assembly 565 can be placed within a fixture such that the handle assembly 565 is positioned in a vertical orientation with the quick connect coupler 551 at the top. The valve holding tube 525 can be coupled to the handle assembly 565 as described above by coupling the quick connect coupler 550 of the valve holding tube 525 to the quick connect coupler 551 of the handle assembly 565. The outer funnel 564 can be coupled to the valve holding tube 525 by coupling the quick connect coupler 543 of the outer funnel 564 to the quick connect coupler 541 of the valve holding tube 525. Thus, the handle assembly 565, valve holding tube 525 and outer funnel 564 will be coupled together in a vertical orientation within the fixture. The prosthetic heart valve can be placed within the interior region defined by the outer funnel 564 of the funnel assembly 515. The tether of the valve is threaded through the outer funnel 564, through the valve holding tube 525, and through the centering rod 561 of the handle assembly 565. The tether piercing member 568 can be turned to pierce the tether and secure the tether to the loading device 560. In some embodiments, with an asymmetric prosthetic mitral valve, the valve is loaded into the loading device 560 so that the A2 section of the valve (see PCT application '58826) is loaded upwards. This can ensure that the A2 segment of the valve is compressed in the same way it is delivered to the A2 region of the anterior native leaflet to reduce or prevent LVOT obstruction. The inner funnel or centering cone 562 can then be threadably attached to the outer funnel 564 with mating threaded portions 597 and 598, respectively (see, e.g., FIGS. 22A and 22B) and secured to the outer funnel 564 with a quick connector 545 (e.g., a thumb screw or set screw) that locks the inner funnel/centering cone 562 to the outer funnel 564 as shown, for example, in FIG. 20B.

A syringe can be coupled to a port 548 of the top cap assembly 596 to provide a saline flush to remove all trapped air bubbles within the loading device 560. The valve can also be checked for air, shaken, tapped to remove trapped air, etc. while within the loading device 560. If any bubbles are seen, they can be removed by flushing a saline through the loading device 560 (e.g., with a syringe coupled to the port 548), especially out of any top pockets of the valve. In some cases, the process of loading the prosthetic valve into the valve loading device 560 can be performed with the valve and loading device 560 submerged in a saline/water bath with care being taken to remove all trapped air bubbles within the loading device 560.

In an alternative procedure, the valve can be placed in the outer funnel 564 prior to the outer funnel being coupled to the valve holding tube 525. The outer funnel 564 and centering cone 562 can be coupled together as described above, and the outer funnel 564 can be coupled to the valve holding tube 525 via the quick connect couplers 541 and 543. In some cases, the valve holding tube 525 can be coupled to the handle assembly 565 via the quick connect couplers 550 and 551 prior to the funnel assembly 515 (outer funnel and top cap assembly 596) being coupled to the valve holding tube 525. In other cases, the valve holding tube 525 can be coupled to the handle assembly 565 prior to the funnel assembly 515 being coupled thereto.

With the funnel assembly 515 (with prosthetic valve loaded therein) coupled to the valve holding tube 525 and handle assembly 565, the entire assembly can be removed from the fixture, flipped upside down, and placed back in the fixture in a vertical orientation, now with the distal end of the handle assembly 565 at the top and the funnel assembly 515 at the bottom. A saline flush can continue to be used (e.g., introduced through port 548) during the procedure to move the valve from the funnel assembly 515 to the valve holding tube 525. To move the prosthetic valve from the funnel assembly 515 (i.e., outer funnel 564/centering cone 562) into an interior region of the valve holding tube 525, the main loading knob or handle 567 is actuated (e.g., rotated) which in turn moves the loading leadscrew 566 in the direction of arrow A relative to the handle 567, as shown in FIG. 23. As the loading leadscrew 566 is moved in the direction of arrow A, because the valve holding 525 is coupled to the loading leadscrew 566 via the quick connect couplers 550, 551 and to the funnel assembly 515 via the quick connect couplers 541, 543, the valve holding tube 525 and the funnel assembly 515 also move with the loading leadscrew 566 in the direction of arrow A, as shown in FIG. 24. FIG. 23 illustrates the valve holding tube 525 and funnel assembly 515 and loading leadscrew 566 prior to being moved proximally, and FIG. 24 illustrates the valve holding tube 525 and funnel assembly 515 and loading leadscrew 566 after being moved proximally in the direction of arrow A, relative to the handle assembly 565.

The prosthetic valve (not shown) (disposed within the funnel assembly 515) remains in a fixed position relative to the handle 567 due to the tether (attached to the valve) being secured to the handle assembly 565 (and handle 567) via the tether piercing member 568. Similarly, the centering rod 561 remains in a fixed position due to being held by the centering rod securement knob 569, which remains fixed axially relative to the handle 567. Thus, as the valve holding tube 525 and the funnel assembly 515 move in the direction of arrow A, the prosthetic valve (and centering rod 561) do not move, and the funnel assembly 515 and the valve holding tube 525 move over the prosthetic valve until the prosthetic valve is captured within an interior region of the valve holding tube 525. With the prosthetic valve within the valve holding tube 525, the valve holding tube 525 can be disconnected from the outer funnel 564 and the handle assembly 565. The valve holding tube 525 can then be coupled to a valve delivery device (e.g., 100, 200) as described herein to be delivered to a heart.

Although the above method of moving a prosthetic valve from being disposed within the funnel assembly 515 to being disposed within the valve holding tube 525 included moving the loading leadscrew 566 in the direction of arrow A to then move the funnel assembly 515 and valve holding tube 525 in the direction of arrow A, in an alternative method, the loading leadscrew 566 can be actuated to move in the opposite direction (i.e., in the direction of arrow B in FIGS. 23 and 24). In such a method, because the tether is coupled/secured to the tether retention mechanism 568, and the retention mechanism is in a fixed relation to the actuator/handle 567, if the actuator/handle 567 is moved in the direction of arrow B, the tether will be moved in the same direction along with the actuator/handle 567. Thus, the tether (coupled to the valve) can pull the prosthetic valve out of the funnel assembly 515 and within the valve holding tube 525.

FIG. 25 illustrates an alternative embodiment of a valve loading device 560′ which can include the same or similar features and can function the same as or similar to the valve loading device 560. For example, the valve loading device 565′ includes a funnel assembly 515′ having an outer funnel 564′ and an inner funnel 562, a valve holding tube 525′ and a handle assembly 565′ with a loading leadscrew 566′. FIG. 25 illustrates the valve loading device after being actuated to move the valve holding tube 525′ and funnel assembly 515′ in the direction of arrow A. More details regarding the valve loading device 560′ are described in provisional application Nos. 62/148,579 and 62/312,136, incorporated by reference above.

FIG. 26 is a flowchart illustrating a method of deploying a prosthetic mitral valve into a heart, according to an embodiment. At 670, a prosthetic mitral valve is loaded into a valve loading device (e.g., 160, 560) and moved from a biased expanded configuration to a compressed configuration within the valve loading device. At 672, the prosthetic mitral valve is transferred to a valve holding tube (e.g., 125, 225, 525) while maintaining the compressed configuration. At 674, the valve holding tube with the prosthetic mitral valve disposed therein in a compressed configuration is coupled to a distal end portion of a handle assembly of a valve delivery device (e.g., 100, 200). Prior to coupling the valve holding tube to the distal end of the handle assembly, a tether coupled to the prosthetic mitral valve can be threaded through a lumen of the handle assembly and through a lumen of a tether retention mechanism (e.g., 127, 227) of the handle assembly. At 676, the valve holding tube can be coupled to a hub of a catheter assembly (e.g., 130, 230) of the valve delivery device. Thus, the proximal end of the valve holding tube is coupled to the handle assembly and the distal end of the valve holding tube is coupled to the catheter assembly. At 678, the distal end of the catheter assembly is inserted into a heart and extended to the left atrium of the heart. For example, with the valve holding tube coupled to the catheter assembly and to the handle assembly, the distal end of the sheath of the catheter assembly can be inserted into the heart. At 680, a proximal actuator knob is actuated such that the prosthetic mitral valve is moved distally out of the valve holding tube and into a distal end portion of the delivery sheath. At 682, a distal actuator knob is actuated to move the delivery sheath proximally such that the prosthetic mitral valve is disposed outside a distal end of the delivery sheath and within the left atrium of the heart. The prosthetic mitral valve is moved to a biased expanded configuration within the heart when uncompressed within the holding tube and delivery sheath.

FIG. 27 is a schematic illustration of a kit according to an embodiment. In some embodiments, a surgical kit 705 can include a delivery device 700 which can be, for example, a delivery device as described herein (e.g., delivery device 100, 200, 300) and a valve loading device 760 (e.g., valve loading device 160, 560). A kit 705 can also optionally include a recapture device 710 (e.g., 410, 1010, 1110, 1210, 1310). A kit 705 can optionally include one or more of a transcatheter prosthetic valve 740 (e.g., a prosthetic mitral valve) and/or an epicardial pad 784 to secure the transcatheter valve 740 in position within the heart and/or a dilator device 754 (e.g., dilator device 354, 854, 954) as described herein and/or a guidewire (not shown in FIG. 23). A kit 705 can also include a sterile package 794 in which the components of the kit can be sealed for transport.

FIGS. 28-42 illustrate another embodiment of a dilator device that can be used with a delivery device (not shown with respect to FIGS. 28-42), such as, for example, the delivery devices 100, 200, 300 described above. A dilator device 854 can be inserted through a port of a catheter assembly, such as the port 237 of catheter 230 or the port 337 of catheter assembly 330 described above. A hemostasis valve (not shown) can be coupled to the side port such that the dilator device 854 is passed through the hemostasis valve when inserted through the side port 227, 337.

As shown in the side view of FIG. 28, the dilator device 854 includes an expandable dilator balloon member 834 (also referred to herein as “balloon member”) that has a tapered distal end that can provide a lead-in for a delivery sheath (not shown) (such as the delivery sheath 336 described above), and used to help open or enlarge the entry opening at the epicardial surface of the heart and through the wall of the ventricle, e.g. at the apex. The balloon member 834 is shown in FIGS. 28, 30, and 34-42 in a partially inflated or almost fully inflated configuration.

The balloon member 834 is coupled to a balloon manifold 856 via an elongate inflation tube 855. The balloon manifold 856 can be the same as or similar to the balloon manifold 356 described above and includes an inflation port 888 and a guidewire port 889. The inflation port 888 can be coupled to a source of an inflation medium used to inflate and deflate the balloon member 834. The elongate inflation tube 855 (also referred to herein as “inflation tube”) is coupled to the balloon manifold 856 and to the balloon member 834 as described in more detail below. The inflation tube 855 defines an inflation lumen in fluid communication with an interior region of the balloon member 834 such that the inflation medium can travel through the inflation port 888, through the inflation lumen, and into the balloon member 834. The dilator device 854 also includes an elongate guidewire tube 857 (also referred to herein as “guidewire tube”) that is coupled to a distal neck portion 839 of the balloon member 834 (described in more detail below) and extends through the balloon member 834, the inflation lumen of the inflation tube 855 and out a proximal end of the inflation tube 855. The guidewire tube 857 defines a guidewire lumen through which a guidewire (not shown) can be inserted. The guidewire can be, for example, 0.035 inches in diameter.

FIG. 29 is a cross-sectional view taken along line B-B in FIG. 28. As shown in FIGS. 28 and 29, the balloon manifold 856 includes a manifold hub 858 and a tapered strain relief portion 859 that relieves bending strain of inflation tube 855 relative to relatively rigid manifold hub 858. The manifold hub 858 and the strain relief portion 859 can be coupled together, for example, via adhesive, at, for example, locations 809.

As shown in FIGS. 28 and 29, a shipping mandrel 853 can be inserted through the guidewire lumen of the guidewire tube 857 and includes an elongate member 849 coupled to a proximal knob 847. The elongate member 849 can be inserted through the balloon manifold 856 and the elongate guidewire tube 857 until a distal end is disposed outside a distal end of the inflation tube 857 as shown in FIG. 28. The shipping mandrel 853 can be used to maintain the alignment of the various components of the dilator device 854 and reduce or eliminate the possibility of the guidewire tube 857 collapsing prior to use of the dilator device 854. In this embodiment, the proximal knob 847 of the shipping mandrel 853 can be coupled to the balloon manifold 856 with a quick connect coupler, such as, for example, a Luer lock coupling mechanism. For example, the proximal knob 847 can include a Luer lock feature 852 that can be matingly coupled to a Luer lock feature 890 of the guidewire port 889 of the balloon manifold 856. Before use of the dilator device 854, the shipping mandrel 853 can be removed from the dilator device 854 by releasing the Luer lock feature 852 from the Luer lock feature 890 of the guidewire port 889 and pulling the shipping mandrel 853 proximally such that the shipping mandrel 853 is removed from the elongate guidewire tube 857 and the balloon manifold 856.

FIG. 30 is a side view of the balloon member 834 in the partially inflated/expanded configuration. The balloon member 834 includes a first body portion 831 and a second body portion 833 having a first outer diameter and a second outer diameter, respectively. The second outer diameter is larger than the first outer diameter. Distal end portion of the balloon member 834 includes a tapered concave distal portion 835 and a distal neck portion 839. Proximal end portion of the balloon member 834 includes a cone-shaped portion 838 and a proximal neck portion 881.

The balloon member 834, and the individual portions of the balloon member 834, can have any suitable length. For example, the concave distal portion 835, the first body portion 831, and the second body portion 833 can have a combined length L₁. In some embodiments, the length L₁can be, for example, about 3.723 inches. The concave distal portion 835 can have a length L₂, the first body portion 831 can have a length L₃, and the second body portion 833 can have a length L₄. In some embodiments, the length L₂can be, for example, about 1.350 inches, the length L₃can be, for example, about 1.25 inches, and the length L₄can be, for example, about 0.75 inches. Additionally, in some embodiments, the tapered concave distal portion 835 can include a hydrophilic coating.

In some embodiments, the distal neck portion 839 can have a length L₅that can be, for example, about 0.30 inches, and the proximal neck portion 881 can have a length L₆that can be, for example, about 0.60 inches. The cone-shaped portion 838 can taper from the second body portion 833 to the proximal neck portion 881 at any suitable angle. For example, the taper of the cone-shaped portion 838 relative to the proximal neck portion 838 can be an angle θ₁. In some embodiments, the angle θ₁can be, for example, 25°. When in an uninflated configuration, as shown in FIG. 31, the balloon member 834 can be folded or collapsed to a smaller size for insertion into a delivery sheath.

In some situations, depending on the inflation pressure of the balloon member 834, the concave distal portion 835 can expand to a non-concave shape when the balloon member 834 is expanded to an inflated configuration. In such a case, the distal portion 835 may be tapered, but not concave. In some embodiments, the balloon member 834 can be configured such that the target pressure in the balloon is 2-3 ATM in an inflated configuration for use. At 2-3 ATM, the concave distal portion 835 can be configured to maintain a concave shape or a slightly more straightened tapered shape.

FIG. 32 is an enlarged view of detail C in FIG. 30. As shown in FIG. 32, the balloon member 834 includes a first transition portion 831A and a second transition portion 833A between the first body portion 831 and the second body portion 833. The first transition portion 831A and the second transition portion 833A provide a smooth and radiused transition between the first body portion 831 and the second body portion 833.

FIG. 33 is a distal end view of the balloon member 834 shown in FIG. 30. As shown in FIG. 33, and described above, the outer diameter of the second body portion 833 is larger than the outer diameter of the first body portion 831. For example, in some embodiments, the second body portion 833 can have an outer diameter of about 0.455 inches and the first body portion 831 can have an outer diameter of about 0.445 inches. The first outer diameter can be selected such that, when the first body portion 831 is disposed within a sheath such as sheath 336 described above, there is a smooth transition between the concave distal portion 835 and the sheath 336. Additionally, the first body portion 831 can include a hydrophilic coating. The second outer diameter (of the second body portion 833) can be selected such that, in an expanded configuration, when disposed inside a delivery sheath (such as sheath 336 described above), the second body portion 833 can create a seal against the inner surface of the delivery sheath. Said another way, when unrestrained and in an expanded/inflated configuration, the second outer diameter of the second body portion 833 can be larger than the inner diameter of the sheath.

FIG. 34 is a cross-sectional view taken along the line D-D shown in FIG. 30. As shown in FIG. 34, the distal neck portion 839 has an outer diameter D₁and an inner diameter D₂. In some embodiments, the outer diameter D₁can be, for example, about 0.064 inches and the inner diameter D₂can be, for example, about 0.056 inches.

FIG. 35 is a cross-sectional view taken along the line E-E shown in FIG. 30. As shown in FIG. 35, the proximal neck portion 881 has an outer diameter D₃and an inner diameter D₄. In some embodiments, the outer diameter D₃can be, for example, about 0.1075 inches and the inner diameter D₄can be, for example, about 0.103 inches.

FIG. 36 is a side view of the balloon member 834, the elongate inflation tube 855, and the elongate guidewire tube 857. As described above, the elongate guidewire tube 857 is disposed through the balloon inflation tube 855. A distal portion of the elongate guidewire tube 857 extends distally of the balloon member 834 and a proximal portion of the elongate guidewire tube 857 extends proximally of the proximal end of the elongate inflation tube 855 by a length L₇. The length L₇can be any suitable length that can engage with the balloon inflation manifold 856 (shown in FIGS. 28 and 29) such that the guidewire lumen defined by the elongate guidewire tube 857 is accessible via the guidewire port 889. For example, in some embodiments, the length L₇can be about 0.668 inches.

FIG. 37 is an enlarged view of detail F identified in FIG. 36. As shown in FIG. 37, the distal neck portion 839 of the balloon member 834 can be coupled to the elongate guidewire tube 857 via an adhesive 883. The adhesive 883 can be applied such that it creates a smooth taper transition region between the outer surface of the elongate guidewire tube 857 and the outer surface of the distal neck portion 839. The taper of the adhesive 883 can be over a length L₈, which, in some embodiments can be, for example, about 0.04 inches.

FIG. 38 is a cross-sectional view of the enlarged detail of FIG. 37 taken along the line G-G in FIG. 32. As shown in FIG. 38, the adhesive 883 coupling the elongate inflation tube 855 to the distal neck portion 839 of the balloon member 834 can also be disposed over a length L₉between an inner surface of the distal neck portion 839 and the outer surface of the elongate guidewire tube 857. In some embodiments, the length L₉can be, for example, between about 0.160 inches and about 0.320 inches.

Additionally, as shown in FIG. 38, the elongate guidewire tube 857 can include a first portion 885 at a distal end (also referred to as distal end portion 885) that can be formed with a softer material than a remaining second portion 807 of the elongate guidewire tube 857 to provide an atraumatic distal end to reduce potential trauma to surrounding tissue when inserted into a patient's heart. For example, in some embodiments, the distal end portion 885 can be formed with a low durometer material, such as, Pebax®, cross-linked Pebax®, nylon, urethane, or the like. The elongate guidewire tube 857 can be disposed within the distal neck portion 839 such that the distal end portion 885 of the elongate guidewire tube 857 overlaps the distal neck portion 839 of the balloon member 834 by a length L₁₀. In some embodiments, the length L₁₀can be, for example, about 0.080 inches. The remaining second portion 807 of the guidewire tube 857 can be formed with multiple layers to provide improved guidewire movement, kink resistance and bondability. For example, in some embodiments, the remaining second portion 807 of the guidewire tube 857 can be formed with a three layer construction including an inner layer of PTFE/PI composite material, a coil material formed with, for example, 304V Stainless steel, and an outer layer of material formed with Pebax® 7233 SA01 for medical use. The first or distal end portion 885 of the guidewire tube 857 can have a larger inner diameter than an outer diameter of the second portion 807 of the guidewire tube 857 such that a distal end of the second portion 807 can be received within the lumen of the distal end portion 885. The first or distal end portion 885 can also be coupled to the second portion of the guidewire tube 857 with an adhesive disposed between the outer surface of the remaining portion and the distal end portion 885.

FIG. 39 is a side view of the balloon member 834 coupled to the elongate inflation tube 855. As shown in FIG. 39, the proximal neck portion 881 of the balloon member 834 can be coupled to the elongate inflation tube 855. Also as shown, the elongate inflation tube 855 can have a length L₁₁. In some embodiments, the length L₁₁can be, for example, about 11.12 inches. The elongate inflation tube 855 can be coupled to the balloon member 834 via an adhesive 886.

FIG. 40 is an enlarged view of detail H in FIG. 39. As shown in FIG. 40, a distal end portion 871 of the elongate inflation tube 855 is disposed within the proximal neck portion 881 of the balloon member 834. The proximal neck portion 881 can have a diameter D₅, which in some embodiments can be, for example, about 0.116 inches or less. The distal end portion 871 of the elongate inflation tube 855 can have a smaller outer diameter D₆than a diameter D₇of the remaining portion 873 of the inflation tube 855 such that it can be inserted into the proximal neck portion 881 of the balloon member 834 (as shown in FIGS. 41 and 42). For example, in some embodiments, the diameter D₆of the distal end portion 871 can be 0.099 inches, and the diameter D₇of the remaining portion 873 of the inflation tube 855 can be, for example, 0.113 inches. In some embodiments, an inner diameter of the distal end portion 871 can be the same as inner diameter of the remaining portion 873 of the inflation tube 855 as shown in FIG. 41. In some embodiments, the distal end portion 871 and the remaining portion 873 of the inflation tube 855 can be formed as an integral or monolithically formed component. In some embodiments, the distal end portion 871 and the remaining portion 873 of the inflation tube 855 can be separate components that are coupled together.

As shown in FIG. 40, in some embodiments, the distal end portion 871 of the inflation tube 855 can be disposed a length L₁₃into the proximal neck portion 881 of the balloon member 834. In some embodiments, the length L₁₃can be, for example, at least about 0.125 inches. An adhesive 886 can be disposed between the proximal neck portion 881 of the balloon member 834 and the distal end portion 871 of the elongate inflation tube 855 to securely couple the proximal neck portion 881 to the elongate inflation tube 855. In some embodiments, the distal end portion 871 is inserted into the proximal neck portion 881 such that there is a small gap between the proximal end of the neck portion 881 and the larger diameter portion 873 of the inflation tube 885 and the adhesive 886 can be disposed within this gap and smoothed along the outer surface of the two components. The adhesive 886 can provide a smooth, tapered transition between the outer surface of the proximal neck portion 881 and the outer surface of elongate inflation tube 855. In some embodiments, the adhesive 886 can be disposed over a length L₁₂, which can be, for example, about 0.02 inches.

In use, as described above, the dilator device 854 can be used in conjunction with a delivery device such as the delivery devices 100, 200, 300, described above, to deliver and deploy a prosthetic mitral valve within a heart. When in an uninflated configuration (not shown), the dilator device 854 can be folded or collapsed and inserted through the hemostasis valve (not shown) coupled to a port of a hub of a catheter assembly (e.g., a port 237, 337 of a hub 232, 332 of a catheter assembly 230, 330). The dilator device 854 can be pushed or moved distally within the lumen of the delivery sheath 236, 336 until the concave distal portion 835 of the balloon member 834 extends distally of the distal end of the delivery sheath 236, 336 and the first body portion 831 and the second body portion 833 are disposed within the delivery sheath 236, 336. In some embodiments, the dilator device 854 can include a marker 875 (see FIG. 39) on an exterior of the inflation tube 855 to assist in the positioning of the dilator device 854 within the delivery sheath 236, 336. For example, the marker 875 can be disposed on the inflation tube 855 at a location such that as the dilator device 854 is inserted into the delivery sheath, when the marker 875 reaches the hemostasis valve coupled to the side port of the delivery sheath, the balloon 834 will be positioned at the correct location within the delivery sheath.

With the dilator device 854 coupled to the catheter assembly (e.g., disposed within the delivery sheath 236, 336 of the catheter assembly 230, 330), the catheter assembly can be coupled to or docked with the handle assembly of the delivery device (e.g., handle assembly 220, 320 of delivery device 200, 300). The shipping mandrel 853 can be decoupled from the guidewire port 889 and removed from the elongate guidewire tube 857 before or after the catheter assembly (e.g., 230, 330) is docked/coupled to the handle assembly (e.g., 220, 320) of the delivery device (e.g., 200, 300). After coupling the catheter assembly (with the dilator device coupled thereto) to the handle assembly, the delivery sheath can be purged of air and the balloon member 834 can be expanded from the uninflated configuration (e.g., folded or collapsed) to an inflated configuration such that the second body portion 833 creates a seal against the inner surface of the delivery sheath 236, 336. The entire assembly can be loaded over a guidewire (not shown) via the distal end of the lumen of the elongate guidewire tube 857. For example, a guidewire can be inserted into the patient's heart and extend outside the patient's body and a proximal end of the guidewire can be inserted into the distal end of the guidewire tube 857 and extended out the proximal end of the guidewire tube 857. With the guidewire inserted therethrough, the distal end portion of the dilator device 854 and delivery sheath 236, 336 can be inserted through the epicardial surface of the patient's heart (e.g. at the apex) and extended through the wall of the left ventricle and into the left atrium of the heart. The tapered distal end of the balloon member 834 helps to open or enlarge the entry opening at the epicardial surface. When the delivery sheath 236, 336 is in a desired location, the balloon member 834 can be deflated and the dilator device 854 can be removed from the delivery device 200, 300 via the port 237, 337. Then delivery device 200, 300 can be actuated to deliver the prosthetic mitral valve as described above with reference to previous embodiments.

FIG. 43 is side view of a balloon member 934 engaged with a sheath 936 shown in cross-section. The balloon member 934 can be similar to the balloon member 934. For example, the dilation device 934 includes a first body portion 931 and a second body portion 933 having a first outer diameter and a second outer diameter, respectively. The second outer diameter is larger than the first outer diameter. The balloon member 934 also includes a tapered concave distal portion 935 and a distal neck portion 939. On the proximal side, the balloon member 934 includes a cone-shaped proximal portion 938 and a proximal neck portion 981.

In this embodiment, the balloon member 934 also includes an enlarged portion 987. The enlarged portion 987 can be shaped as a ring and has an increased outer diameter relative to the first body portion 931 when inflated (as shown in FIG. 43). The sheath 936 can be the same as or similar to the delivery sheaths 236 or 336 described above. As shown in FIG. 43, the sheath 936 can abut the proximal side of the enlarged portion 987. As a result of the abutment of the sheath 936 with the enlarged portion 987, the transition between the balloon 934 and the sheath 936 is smooth. Said another way, as the balloon member 934 and sheath 936 are moved through the epicardial surface, tissue will not catch on the distal end of the sheath 936. Additionally, the enlarged portion 987 can act as a limit or stop for the sheath 936 such that when the balloon member 934 is in the inflated configuration, the sheath 936 cannot translate distally beyond the enlarged portion 987.

FIGS. 44-46 illustrate another embodiment of a recapture device that can be used to recapture a deployed/implanted prosthetic heart valve (e.g., prosthetic mitral valve) to reposition and/or retrieve/remove the prosthetic heart valve. A recapture device 1010 includes an outer sheath 1044 coupled to a handle assembly 1020, an outer dilator 1042 operatively coupled to the handle assembly 1020 and movably disposed within a lumen of the outer sheath 1044, and an inner dilator 1046 movably disposed within a lumen of the outer dilator 1042 and operatively coupled to the handle assembly 1020. In this embodiment, the recapture device 1010 includes a tether retention mechanism that is incorporated into the actuator assembly as described in more detail below. The inner dilator 1046 defines a lumen that can receive a tether extending from a prosthetic valve (not shown) and can receive a portion of the prosthetic valve during a recapture procedure. The inner dilator 1046 also includes a distal tip configured to engage the prosthetic valve implanted within a heart as described in more detail below.

As shown in FIG. 46, the handle assembly 1020 includes a housing 1022, an actuator knob 1026 coupled to the housing 1022 and operatively coupled to a drive shaft mechanism 1006. The drive shaft mechanism 1006 is operatively coupled to the inner dilator 1046 and includes a winding housing 1077 that winds the tether (extending from the prosthetic valve) during the recapture procedure as described in more detail below. A first spring 1091 is coupled to an elongate tube 1079 and to the inner dilator 1046. The first spring 1091 can be, for example a coil spring. The outer dilator 1042 is coupled to an elongate rod 1093 which is coupled to a pair of tape springs 1092, which can be, for example, constant force springs, or variable force springs.

To capture a prosthetic heart valve with the recapture device 1010, the tether extending from the prosthetic valve can be inserted through a distal end of the inner dilator 1046, extend through the lumen of the inner dilator 1046, through the elongate tube 1079, through the winding housing 1077, through a hypotube 1018 and out a proximal end of the recapture device 1010. A Touhy valve 1017 is coupled to the hypotube 1018 and is configured to clamp the tether thereto and provide resistance as the tether is wound during a recapture procedure as described below. The valve 1017 can also provide a seal to allow for a saline flush of the system.

With the tether threaded through the recapture device 1010, the distal tip of the inner dilator 1046 can be moved distally along the tether to engage a proximal portion of the prosthetic valve. The actuator 1026 can then be actuated (e.g., rotate or turn the knob) to move the inner dilator 1046 proximally relative to the outer dilator 1042. As the inner dilator 1046 is moved proximally, the tether is wound within the winding housing 1077, and the valve will in turn be pulled proximally. For example, the tether can be wound from both directions into the winding housing 1077. One direction coming from the tether extending into the hypotube 1018 and the other direction being the tether entering the housing 1077 from the elongate tube 1079. The inner dilator 1046 can continue to be actuated to move proximally relative to the outer dilator 1042 pulling the prosthetic valve partially within the lumen of the outer dilator 1042 until the spring 1091 collapses fully and bottoms out against the outer dilator 1042 and the force on the spring 1091 increases. At this point, the valve has been partially captured and can be repositioned within the heart if desired.

To fully capture and retrieve/remove the valve, the actuator 1026 can continue to be actuated (e.g., rotated/turned), and due to the force of the spring 1091 against the outer dilator 1042, the outer dilator 1042 will begin to move proximally with the inner dilator 1046 and the valve coupled thereto. In other words, the inner dilator 1046 pulls the outer dilator 1042 proximally relative to the outer sheath 1044. The outer sheath 1044 remains fixed relative to the handle assembly 1020. As the outer dilator 1042 is moved proximally, the elongate rod 1093 engages with the tape springs 1092 and slides within a slot 1094. The springs 1092 coupled to the outer dilator 1042 via the elongate rod 1093 can control the force used to move the outer dilator 1042 proximally. In some embodiments, the springs 1092 can provide a constant force of, for example, 8-10 lbs. In some embodiments, the springs 1092 can provide a variable force. For example, it may be desirable to provide a greater spring force at the start of the actuation of the outer dilator 1042. As the outer dilator 1042 is moved proximally, the valve is pulled fully into the lumen of the outer sheath 1044 and moved to a collapsed configuration. The valve can then be removed/retrieved from the heart by removing the recapture device 1010 from the patient's body with the valve therein.

FIGS. 47-49 illustrate another embodiment of a recapture device that can be used to recapture a deployed/implanted prosthetic heart valve (e.g., prosthetic mitral valve) to reposition and/or retrieve/remove the prosthetic heart valve. A recapture device 1110 includes an outer sheath 1144 coupled to a handle assembly 1120, an outer dilator 1142 operatively coupled to the handle assembly 1120 and movably disposed within a lumen of the outer sheath 1144, and an inner dilator 1146 movably disposed within a lumen of the outer dilator 1142 and operatively coupled to the handle assembly 1120. As with the previous embodiment, the recapture device 1110 includes a tether retention mechanism that is incorporated into the actuator assembly as described in more detail below. The inner dilator 1146 defines a lumen that can receive a tether extending from a prosthetic valve (not shown) and can receive a portion of the prosthetic valve during a recapture procedure. The inner dilator 1146 also includes a distal tip configured to engage the prosthetic valve implanted within a heart as described in more detail below.

As shown in FIG. 48, the handle assembly 1120 includes a housing 1122, an actuator knob 1126 coupled to the housing 1122 and operatively coupled to a drive shaft mechanism 1106. The drive shaft mechanism 1106 is operatively coupled to the inner dilator 1146 and includes a winding housing 1177 that winds the tether (extending from the prosthetic valve) during the recapture procedure as described in more detail below. A first spring 1191 is coupled to an elongate tube 1179 and to the inner dilator 1146. The first spring 1191 can be, for example a coil spring. In this embodiment, the outer dilator 1142 is coupled to the elongate rod 1179 which is also coupled to a second spring 1192, which can also be, for example, a coil spring. The spring 1191 has a softer spring rate than the second spring 1192. A release lever 1195 is couple to the drive shaft mechanism 1106 and can prevent the drive mechanism 1106 from moving backwards during a recapture procedure. If desired, however, the release lever 1195 can be actuated to allow the drive mechanism to back up if needed.

To capture a prosthetic heart valve with the recapture device 1110, the tether extending from the prosthetic valve can be inserted through a distal end of the inner dilator 1146, extend through the lumen of the inner dilator 1146, through the elongate tube 1179, through the winding housing 1177, through a hypotube 1118 and out a proximal end of the recapture device 1110. A Touhy valve 1117 is coupled to the hypotube 1118 and is configured to clamp the tether thereto and provide resistance as the tether is wound during a recapture procedure as described below. The valve 1117 can also provide a seal to allow for a saline flush of the system.

With the tether threaded through the recapture device 1110, the distal tip of the inner dilator 1146 can be moved distally along the tether to engage a proximal portion of the prosthetic valve. The actuator 1126 can then be actuated (e.g., rotate or turn the knob) to move the inner dilator 1146 proximally relative to the outer dilator 1142. As the inner dilator 1146 is moved proximally, the tether is wound within the winding housing 1177, and the valve will in turn be pulled proximally. For example, the tether can be wound from both directions into the winding housing 1177. One direction coming from the tether extending into the hypotube 1118 and the other direction being the tether entering the housing 1177 from the elongate tube 1179. The inner dilator 1146 can continue to be actuated to move proximally relative to the outer dilator 1142 pulling the prosthetic valve partially within the lumen of the outer dilator 1142 until the spring 1191 collapses fully and bottoms out against the outer dilator 1142 and the force on the spring 1191 increases. At this point, the valve has been partially captured and can be repositioned within the heart if desired.

To fully capture and retrieve/remove the valve, the actuator 1126 can continue to be actuated (e.g., rotated/turned), which will cause the outer dilator 1142 to begin to move proximally with the inner dilator 1146 and the valve coupled thereto. In other words, the inner dilator 1146 pulls the outer dilator 1142 proximally relative to the outer sheath 1144. The outer sheath 1144 remains fixed relative to the handle assembly 1120. As the outer dilator 1142 is moved proximally, the outer dilator 1142 applies a force against the second spring 1192. The second spring 1192 can help control the force used to move the outer dilator 1142 proximally. In some embodiments, the spring 1192 can provide a constant force of, for example, 8-10 lbs. In some embodiments, the springs 1191 and 1192 can each provide a variable force. As the outer dilator 1142 is moved proximally, the valve is pulled fully into the lumen of the outer sheath 1144 and moved to a collapsed configuration. The valve can then be removed/retrieved from the heart by removing the recapture device 1110 from the patient's body with the valve therein.

FIGS. 50-52 illustrate another embodiment of a recapture device that can be used to recapture a deployed/implanted prosthetic heart valve (e.g., prosthetic mitral valve) to reposition and/or retrieve/remove the prosthetic heart valve. A recapture device 1210 includes an outer sheath 1244 coupled to a handle assembly 1220, an outer dilator 1242 operatively coupled to the handle assembly 1220 and movably disposed within a lumen of the outer sheath 1244, and an inner dilator 1246 movably disposed within a lumen of the outer dilator 1242 and operatively coupled to the handle assembly 1220. The inner dilator 1246 defines a lumen that can receive a tether (not shown) extending from a prosthetic valve (not shown) and can receive a portion of the prosthetic valve during a recapture procedure. The inner dilator 1146 also includes a distal tip configured to engage the prosthetic valve implanted within a heart as described in more detail below. In this embodiment, the recapture device 1210 includes a tether retention mechanism 1227 that includes a pinning member that can pierce the tether and secure the tether to the recapture device 1210.

As shown in FIG. 52, the handle assembly 1220 includes a housing 1222, a first actuator knob 1226 operatively coupled to the inner dilator 1246, and a second actuator knob 1228 operatively coupled to the outer dilator 1242. An elongate tube 1279 is coupled to the inner dilator 1246 and extends through the housing 1222 and is coupled to the tether retention mechanism 1227.

To capture a prosthetic heart valve with the recapture device 1210, the tether extending from the prosthetic valve can be inserted through a distal end of the inner dilator 1246, extend through the lumen of the inner dilator 1246, through the elongate tube 1279, and is pinned by the retention mechanism 1227 at a proximal end of the handle assembly 1220. With the tether threaded through the recapture device 1210, the distal tip of the inner dilator 1246 can be moved distally along the tether to engage a proximal portion of the prosthetic valve. The first actuator 1226 can then be actuated (e.g., rotate or turn the knob) to move the inner dilator 1246 proximally relative to the outer dilator 1242. As the inner dilator 1246 is moved proximally, the retention mechanism 1227 and tether coupled thereto are pulled with the inner dilator 1246, and the valve will in turn be pulled proximally. As the valve is pulled proximally, a portion of the valve will be pulled into the lumen of the outer dilator 1242 and moved to a collapsed configuration within the lumen. At this point, the valve has been partially captured and can be repositioned within the heart if desired.

To fully capture and retrieve/remove the valve, the second actuator knob 1228 can be actuated (e.g., rotated/turned), which will cause the outer dilator 1242 to begin to move proximally with the inner dilator 1246 and the valve coupled thereto. The outer sheath 1244 remains fixed relative to the handle assembly 1220. The outer dilator 1242 can be moved proximally until the valve is fully disposed within the outer sheath 1244 and moved to a collapsed configuration. The valve can then be removed/retrieved from the heart by removing the recapture device 1210 from the patient's body with the valve disposed therein.

FIGS. 53-56 illustrate another embodiment of a recapture device that can be used to recapture a deployed/implanted prosthetic heart valve (e.g., prosthetic mitral valve) to reposition and/or retrieve/remove the prosthetic heart valve. A recapture device 1310 includes an outer sheath 1344 coupled to a handle assembly 1320, an outer dilator 1342 operatively coupled to the handle assembly 1320 and movably disposed within a lumen of the outer sheath 1344, and an inner dilator 1346 movably disposed within a lumen of the outer dilator 1342 and operatively coupled to the handle assembly 1320. The inner dilator 1346 defines a lumen that can receive a tether (not shown) extending from a prosthetic valve (not shown) and can receive a portion of the prosthetic valve during a recapture procedure. The inner dilator 1346 also includes a distal tip configured to engage the prosthetic valve implanted within a heart as described in more detail below. In this embodiment, the recapture device 1310 includes a tether retention mechanism 1327 that includes a pinning member that can pierce the tether and secure the tether to the recapture device 1310.

As shown in FIGS. 55 and 56, the handle assembly 1320 includes a housing 1322, an elongate threaded member 1308, and an actuator knob 1326. The actuator knob 1326 is operatively coupled to the inner dilator 1346 and to the outer dilator 1342. An elongate tube 1379 is coupled to the actuator knob 1326 and also to the inner dilator 1346 and to the outer dilator 1342, and extends through the housing 1322. The actuator knob 1326 can be actuated by rotating the actuator knob 1326, which causes the actuator knob to travel along the threaded member 1308. The tether retention mechanism 1327 is operatively coupled to the actuator knob 1326 such that when the actuator knob is actuated (e.g., rotated/turned) the tether retention mechanism 1327 moves with the actuator knob 1326 relative to the threaded member 1308. As shown in FIG. 53, the pinning member of the tether retention mechanism 1327 extends out a slot of the elongate threaded member 1308, and the tether retention mechanism 1327 can move along the slot 1307 as the actuator knob 1326 is actuated. In some embodiments, the actuator knob 1326 and/or threaded member 1308 includes a one-way mechanism that only allows the actuator knob 1326 to travel along the threaded member 1308 in one direction. This can prevent the actuator knob 1326 from being inadvertently moved back distally during a recapture procedure. A release lever 1319 is coupled to the outer dilator 1342 and is configured to releasably secure the outer dilator 1342 in a fixed position relative to the outer sheath 1344 as described in more detail below.

To capture a prosthetic heart valve with the recapture device 1310, the tether extending from the prosthetic valve can be inserted through a distal end of the inner dilator 1346, extend through the lumen of the inner dilator 1346, through the elongate tube 1379, and is pinned by the retention mechanism 1327. With the tether threaded through the recapture device 1310, the distal tip of the inner dilator 1346 can be moved distally along the tether to engage a proximal portion of the prosthetic valve. With the release lever 1319 engaged (e.g., pushed in) such that the outer dilator 1342 can't move relative to the outer sheath 1344, the actuator knob 1326 can be actuated (e.g., rotate or turn the knob) to move the inner dilator 1346 proximally relative to the outer dilator 1342 and relative to the outer sheath 1344. As the inner dilator 1346 is moved proximally, the retention mechanism 1327 and tether coupled thereto move proximally with the inner dilator 1346, and the valve will in turn be moved proximally such that a portion of the valve will be pulled into the lumen of the outer dilator 1342 and moved to a collapsed configuration within the lumen of the outer dilator 1342. At this point, the valve has been partially captured and can be repositioned within the heart if desired.

To fully capture and retrieve/remove the valve, the release lever 1319 can be pulled or moved to release the outer dilator 1342 from the outer sheath 1344. The actuator knob 1326 can be actuated to travel further proximally along the elongate threaded member 1308 which will cause the outer dilator 1342 to move proximally with the inner dilator 1346 and the valve coupled thereto. The outer sheath 1344 remains fixed relative to the handle assembly 1320. The outer dilator 1342 can be moved proximally until the valve is fully disposed within the lumen of the outer sheath 1344 and moved to a collapsed configuration. The valve can then be removed/retrieved from the heart by removing the recapture device 1310 from the patient's body with the valve disposed therein.

As described above for recapture device 410, each of the recapture devices described herein (i.e., 410, 1010, 1110, 1210, 1310) include a two-stage actuation of the recapture device that allows for a controlled capture of a prosthetic valve implanted within a heart to reposition and/or remove/retrieve the prosthetic valve. The proximal portion of the frame of the valve can first be collapsed sufficiently for a portion of the frame to be disposed within the lumen of the outer dilator (e.g., 442, 1042, 1142, 1242, 1342), and then can transition into a more fully collapsed configuration as it is moved into the lumen of the outer sheath (e.g., 444, 1044, 1144, 1244, 1344).

While various embodiments have been described above, it should be understood that they have been presented by way of example only, and not limitation. Where methods described above indicate certain events occurring in certain order, the ordering of certain events may be modified. Additionally, certain of the events may be performed concurrently in a parallel process when possible, as well as performed sequentially as described above.

Where schematics and/or embodiments described above indicate certain components arranged in certain orientations or positions, the arrangement of components may be modified. While the embodiments have been particularly shown and described, it will be understood that various changes in form and details may be made. Any portion of the apparatus and/or methods described herein may be combined in any combination, except mutually exclusive combinations. The embodiments described herein can include various combinations and/or sub-combinations of the functions, components, and/or features of the different embodiments described.

Claims

1. An apparatus, comprising: a recapture device configured to reposition or remove a prosthetic heart valve deployed within a heart, the recapture device including an outer sheath, an outer dilator, an inner dilator, and a handle assembly,the outer sheath defining a first lumen,the outer dilator defining a second lumen and movably disposed at least partially within the first lumen of the outer sheath,the inner dilator defining a third lumen and movably disposed at least partially within the second lumen of the outer dilator, the inner dilator including a distal tip configured to engage a proximal portion of the prosthetic heart valve,the handle assembly operatively coupled to the inner dilator and operatively coupled to the outer sheath, the handle assembly including a tether retention mechanism configured to secure a tether extending from the prosthetic heart valve to the handle assembly,the inner dilator configured to be actuated to move the inner dilator proximally relative to the outer dilator when the tether extending from the prosthetic heart valve is secured to the tether retention mechanism such that a first portion of the prosthetic heart valve moves within the second lumen of the outer dilator and to a collapsed configuration,the outer sheath configured to be actuated to move the outer sheath distally relative to the inner dilator and relative to the outer dilator such that a second portion of the prosthetic heart valve, distal of the first portion of the prosthetic heart valve, moves within the first lumen of the outer sheath and to a collapsed configuration.
2. The apparatus of claim 1, wherein the first portion of the prosthetic heart valve and the second portion of the prosthetic heart valve collectively form an entirety of the prosthetic heart valve such that the entire prosthetic heart valve is disposed within the outer sheath.
3. The apparatus of claim 1, wherein the handle assembly further includes a first actuator operatively coupled to the inner dilator and a second actuator operatively coupled to the outer sheath, the first actuator configured to move the inner dilator relative to the outer dilator, the second actuator configured to move the outer sheath relative to the inner dilator and relative to the outer dilator.
4. An apparatus, comprising: a recapture device configured to reposition or remove a prosthetic heart valve deployed within a heart, the recapture device including an outer sheath, an outer dilator, an inner dilator, and a handle assembly,the outer sheath defining a first lumen,the outer dilator defining a second lumen and movably disposed at least partially within the first lumen of the outer sheath,the inner dilator defining a third lumen and movably disposed at least partially within the second lumen of the outer dilator, the inner dilator including a distal tip configured to engage a proximal portion of the prosthetic heart valve,the handle assembly including an actuator operatively coupled to the inner dilator and operatively coupled to the outer dilator, the handle assembly further including a tether retention mechanism configured to secure a tether extending from the prosthetic heart valve to the handle assembly,the actuator including a drive mechanism operatively coupled to a first spring coupled to the inner dilator and to a second spring coupled to the outer dilator,wherein when the actuator is actuated, the inner dilator is configured to move proximally relative to the outer dilator when the tether extending from the prosthetic heart valve is secured to the tether retention mechanism such that a first portion of the prosthetic heart valve is pulled within the second lumen of the outer dilator and moved to a collapsed configuration, and when the outer dilator is actuated after the inner dilator is actuated, the outer dilator is configured to move proximally relative to the outer sheath such that a second portion of the prosthetic heart valve, distal of the first portion of the prosthetic heart valve, is pulled within the first lumen of the outer sheath and moved to a collapsed configuration.
5. The apparatus of claim 4, wherein the first portion of the prosthetic heart valve and the second portion of the prosthetic heart valve collectively include an entirety of the prosthetic heart valve.
6. The apparatus of claim 4, wherein the actuator is further operatively coupled to the tether retention mechanism such that the inner dilator and the tether retention mechanism can be actuated to move together.
7. The apparatus of claim 4, wherein the actuator is further operatively coupled to the tether retention mechanism, the tether retention mechanism including a drive shaft configured to wind the tether into a winding housing as the inner dilator and the outer dilator are actuated.
8. The apparatus of claim 4, wherein the second spring comprises a different spring rate than the first spring.
9. The apparatus of claim 4, wherein the first spring includes a coil spring and the second spring includes a tape spring.
10. The apparatus of claim 4, wherein the first spring includes a coil spring and the second spring includes a coil spring.
11. The apparatus of claim 4, further comprising a release lever coupled to the outer dilator and configured to releasably secure the outer dilator in a fixed position relative to the outer sheath.
12. A method, comprising: delivering a retrieval device into a heart such that a portion of the retrieval device is positioned adjacent a prosthetic heart valve implanted within the heart, the retrieval device including an inner dilator movably disposed within a lumen of an outer dilator, the outer dilator being disposed at least partially within a lumen of an outer sheath;inserting a tether extending from the prosthetic heart valve through the lumen of the inner dilator;securing the tether of the prosthetic heart valve to a tether retention mechanism of the retrieval device;engaging a distal tip of the inner dilator to a first portion of the prosthetic heart valve; andactuating the inner dilator to cause the inner dilator to move proximally such that the first portion of the prosthetic heart valve moves within the lumen of the outer dilator and to a collapsed configuration.
13. The method of claim 12, further comprising: repositioning the prosthetic heart valve; andactuating the inner dilator, after the prosthetic heart valve has been repositioned, to cause the inner dilator to move distally such that the first portion of the prosthetic heart valve is deployed from the lumen of the outer dilator and moves to an expanded configuration.
14. The method of claim 12, further comprising: actuating the outer sheath to cause the outer sheath to move distally relative to the outer dilator and the inner dilator such that a second portion of the prosthetic heart valve moves within the lumen of the outer sheath and to a collapsed configuration, the second portion being distal of the first portion of the prosthetic heart valve; andremoving the retrieval device from the heart with the prosthetic heart valve disposed within the lumen of the outer sheath.
15. The method of claim 14, wherein actuating the inner dilator comprises actuating a first actuator disposed on a handle of the retrieval device to move the inner dilator relative to the outer dilator, and actuating the outer sheath comprises actuating a second actuator separate from the first actuator, the second actuator disposed on the handle of the retrieval device, to move the outer sheath relative to the inner dilator and relative to the outer dilator.
16. The method of claim 12, wherein actuating the inner dilator causes the inner dilator and the tether retention mechanism to move together relative to the outer sheath.
17. The method of claim 12, wherein securing the tether of the prosthetic heart valve to the tether retention mechanism comprises piercing the tether with a pinning member.
18. The method of claim 12, further comprising actuating the outer dilator after the inner dilator is actuated, to proximally move the outer dilator relative to the outer sheath such that a second portion of the prosthetic heart valve, distal of the first portion of the prosthetic heart valve, moves within the lumen of the outer sheath to a collapsed configuration.
19. The method of claim 18, further comprising winding the tether into a winding housing as the inner dilator and the outer dilator are actuated.
20. The method of claim 18, further comprising removing the retrieval device from the heart with the prosthetic heart valve completely disposed within the lumen of the outer sheath.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a divisional of U.S. application Ser. No. 15/730,148, filed on Oct. 11, 2017, which is a continuation of International Application No. PCT/US2016/027770, filed on Apr. 15, 2016, which claims priority to and the benefit of U.S. Provisional Patent Application No. 62/312,136, entitled “Apparatus and Methods for Delivery, Repositioning, and Retrieval of Transcatheter Prosthetic Valves,” filed Mar. 23, 2016, and U.S. Provisional Patent Application No. 62/148,579, entitled “Apparatus and Methods for Delivery, Repositioning, and Retrieval of Transcatheter Prosthetic Valves,” filed Apr. 16, 2015, each of the disclosures of which is incorporated herein by reference in its entirety.

US Referenced Citations (745)

Number	Name	Date	Kind
2697008	Ross	Dec 1954	A
3409013	Berry	Nov 1968	A
3472230	Fogarty et al.	Oct 1969	A
3476101	Ross	Nov 1969	A
3548417	Kischer	Dec 1970	A
3587115	Shiley	Jun 1971	A
3657744	Ersek	Apr 1972	A
3671979	Moulopoulos	Jun 1972	A
3714671	Edwards et al.	Feb 1973	A
3755823	Hancock	Sep 1973	A
3976079	Samuels et al.	Aug 1976	A
4003382	Dyke	Jan 1977	A
4035849	Angell et al.	Jul 1977	A
4056854	Boretos et al.	Nov 1977	A
4073438	Meyer	Feb 1978	A
4106129	Carpentier et al.	Aug 1978	A
4222126	Boretos et al.	Sep 1980	A
4265694	Boretos et al.	May 1981	A
4297749	Davis et al.	Nov 1981	A
4339831	Johnson	Jul 1982	A
4343048	Ross et al.	Aug 1982	A
4345340	Rosen	Aug 1982	A
4373216	Klawitter	Feb 1983	A
4406022	Roy	Sep 1983	A
4470157	Love	Sep 1984	A
4490859	Black et al.	Jan 1985	A
4535483	Klawitter et al.	Aug 1985	A
4574803	Storz	Mar 1986	A
4585705	Broderick et al.	Apr 1986	A
4592340	Boyles	Jun 1986	A
4605407	Black et al.	Aug 1986	A
4612011	Kautzky	Sep 1986	A
4626255	Reichart et al.	Dec 1986	A
4638886	Marietta	Jan 1987	A
4643732	Pietsch et al.	Feb 1987	A
4655771	Wallsten	Apr 1987	A
4692164	Dzemeshkevich et al.	Sep 1987	A
4733665	Palmaz	Mar 1988	A
4759758	Gabbay	Jul 1988	A
4762128	Rosenbluth	Aug 1988	A
4777951	Cribier et al.	Oct 1988	A
4787899	Lazarus	Nov 1988	A
4787901	Baykut	Nov 1988	A
4796629	Grayzel	Jan 1989	A
4824180	Levrai	Apr 1989	A
4829990	Fhuroff et al.	May 1989	A
4830117	Capasso	May 1989	A
4851001	Taheri	Jul 1989	A
4856516	Hillstead	Aug 1989	A
4878495	Grayzel	Nov 1989	A
4878906	Lindemann et al.	Nov 1989	A
4883458	Shiber	Nov 1989	A
4922905	Strecker	May 1990	A
4923013	De Gennaro	May 1990	A
4960424	Grooters	Oct 1990	A
4966604	Reiss	Oct 1990	A
4979939	Shiber	Dec 1990	A
4986830	Owens et al.	Jan 1991	A
4994077	Dobben	Feb 1991	A
4996873	Takeuchi	Mar 1991	A
5007896	Shiber	Apr 1991	A
5026366	Leckrone	Jun 1991	A
5032128	Alonso	Jul 1991	A
5037434	Lane	Aug 1991	A
5047041	Samuels	Sep 1991	A
5059177	Towne et al.	Oct 1991	A
5064435	Porter	Nov 1991	A
5080668	Bolz et al.	Jan 1992	A
5085635	Cragg	Feb 1992	A
5089015	Ross	Feb 1992	A
5152771	Sabbaghian et al.	Oct 1992	A
5163953	Vince	Nov 1992	A
5167628	Boyles	Dec 1992	A
5192297	Hull	Mar 1993	A
5201880	Wright et al.	Apr 1993	A
5266073	Wall	Nov 1993	A
5282847	Trescony et al.	Feb 1994	A
5295958	Shturman	Mar 1994	A
5306296	Wright et al.	Apr 1994	A
5332402	Teitelbaum	Jul 1994	A
5336616	Livesey et al.	Aug 1994	A
5344442	Deac	Sep 1994	A
5360444	Kusuhara	Nov 1994	A
5364407	Poll	Nov 1994	A
5370685	Stevens	Dec 1994	A
5397351	Pavcnik et al.	Mar 1995	A
5411055	Kane	May 1995	A
5411552	Andersen et al.	May 1995	A
5415667	Frater	May 1995	A
5443446	Shturman	Aug 1995	A
5480424	Cox	Jan 1996	A
5500014	Quijano et al.	Mar 1996	A
5545209	Roberts et al.	Aug 1996	A
5545214	Stevens	Aug 1996	A
5549665	Vesely et al.	Aug 1996	A
5554184	Machiraju	Sep 1996	A
5554185	Block et al.	Sep 1996	A
5571175	Vanney et al.	Nov 1996	A
5591185	Kilmer et al.	Jan 1997	A
5607462	Imran	Mar 1997	A
5607464	Trescony et al.	Mar 1997	A
5609626	Quijano et al.	Mar 1997	A
5639274	Fischell et al.	Jun 1997	A
5662704	Gross	Sep 1997	A
5665115	Cragg	Sep 1997	A
5674279	Wright et al.	Oct 1997	A
5697905	d'Ambrosio	Dec 1997	A
5702368	Stevens et al.	Dec 1997	A
5716417	Girard et al.	Feb 1998	A
5728068	Leone et al.	Mar 1998	A
5728151	Garrison et al.	Mar 1998	A
5741333	Frid	Apr 1998	A
5749890	Shaknovich	May 1998	A
5756476	Epstein et al.	May 1998	A
5769812	Stevens et al.	Jun 1998	A
5792179	Sideris	Aug 1998	A
5800508	Goicoechea et al.	Sep 1998	A
5833673	Ockuly et al.	Nov 1998	A
5840081	Andersen et al.	Nov 1998	A
5855597	Jayaraman	Jan 1999	A
5855601	Bessler et al.	Jan 1999	A
5855602	Angell	Jan 1999	A
5904697	Gifford, III et al.	May 1999	A
5925063	Khosravi	Jul 1999	A
5957949	Leonhardt et al.	Sep 1999	A
5968052	Sullivan, III et al.	Oct 1999	A
5968068	Dehdashtian et al.	Oct 1999	A
5972030	Garrison et al.	Oct 1999	A
5993481	Marcade et al.	Nov 1999	A
6027525	Suh et al.	Feb 2000	A
6042607	Williamson, IV et al.	Mar 2000	A
6045497	Schweich, Jr. et al.	Apr 2000	A
6063112	Sgro	May 2000	A
6077214	Mortier et al.	Jun 2000	A
6099508	Bousquet	Aug 2000	A
6132473	Williams et al.	Oct 2000	A
6168614	Andersen et al.	Jan 2001	B1
6171335	Wheatley et al.	Jan 2001	B1
6174327	Mertens et al.	Jan 2001	B1
6183411	Mortier et al.	Feb 2001	B1
6210408	Chandrasekaran et al.	Apr 2001	B1
6217585	Houser et al.	Apr 2001	B1
6221091	Khosravi	Apr 2001	B1
6231602	Carpentier et al.	May 2001	B1
6245102	Jayaraman	Jun 2001	B1
6260552	Mortier et al.	Jul 2001	B1
6261222	Schweich, Jr. et al.	Jul 2001	B1
6264602	Mortier et al.	Jul 2001	B1
6287339	Vazquez et al.	Sep 2001	B1
6299637	Shaolian et al.	Oct 2001	B1
6302906	Goicoechea et al.	Oct 2001	B1
6312465	Griffin et al.	Nov 2001	B1
6332893	Mortier et al.	Dec 2001	B1
6350277	Kocur	Feb 2002	B1
6358277	Duran	Mar 2002	B1
6379372	Dehdashtian et al.	Apr 2002	B1
6402679	Mortier et al.	Jun 2002	B1
6402680	Mortier et al.	Jun 2002	B2
6402781	Langberg et al.	Jun 2002	B1
6406420	McCarthy et al.	Jun 2002	B1
6425916	Garrison et al.	Jul 2002	B1
6440164	DiMatteo et al.	Aug 2002	B1
6454799	Schreck	Sep 2002	B1
6458153	Bailey et al.	Oct 2002	B1
6461382	Cao	Oct 2002	B1
6468660	Ogle et al.	Oct 2002	B2
6482228	Norred	Nov 2002	B1
6488704	Connelly et al.	Dec 2002	B1
6537198	Vidlund et al.	Mar 2003	B1
6540782	Snyders	Apr 2003	B1
6569196	Vesely	May 2003	B1
6575252	Reed	Jun 2003	B2
6582462	Andersen et al.	Jun 2003	B1
6605112	Moll et al.	Aug 2003	B1
6616684	Vidlund et al.	Sep 2003	B1
6622730	Ekvall et al.	Sep 2003	B2
6629534	St. Goar et al.	Oct 2003	B1
6629921	Schweich, Jr. et al.	Oct 2003	B1
6648077	Hoffman	Nov 2003	B2
6648921	Anderson et al.	Nov 2003	B2
6652578	Bailey et al.	Nov 2003	B2
6669724	Park et al.	Dec 2003	B2
6706065	Langberg et al.	Mar 2004	B2
6709456	Langberg et al.	Mar 2004	B2
6723038	Schroeder et al.	Apr 2004	B1
6726715	Sutherland	Apr 2004	B2
6730118	Spenser et al.	May 2004	B2
6733525	Yang et al.	May 2004	B2
6740105	Yodat et al.	May 2004	B2
6746401	Panescu	Jun 2004	B2
6746471	Mortier et al.	Jun 2004	B2
6752813	Goldfarb et al.	Jun 2004	B2
6764510	Vidlund et al.	Jul 2004	B2
6797002	Spence et al.	Sep 2004	B2
6810882	Langberg et al.	Nov 2004	B2
6830584	Seguin	Dec 2004	B1
6854668	Wancho et al.	Feb 2005	B2
6855144	Lesh	Feb 2005	B2
6858001	Aboul-Hosn	Feb 2005	B1
6890353	Cohn et al.	May 2005	B2
6893460	Spenser et al.	May 2005	B2
6896690	Lambrecht et al.	May 2005	B1
6908424	Mortier et al.	Jun 2005	B2
6908481	Cribier	Jun 2005	B2
6936067	Buchanan	Aug 2005	B2
6945996	Sedransk	Sep 2005	B2
6955175	Stevens et al.	Oct 2005	B2
6974476	McGuckin, Jr. et al.	Dec 2005	B2
6976543	Fischer	Dec 2005	B1
6997950	Chawla	Feb 2006	B2
7018406	Seguin et al.	Mar 2006	B2
7018408	Bailey et al.	Mar 2006	B2
7044905	Vidlund et al.	May 2006	B2
7060021	Wilk	Jun 2006	B1
7077862	Vidlund et al.	Jul 2006	B2
7087064	Hyde	Aug 2006	B1
7100614	Stevens et al.	Sep 2006	B2
7101395	Tremulis et al.	Sep 2006	B2
7108717	Freidberg	Sep 2006	B2
7112219	Vidlund et al.	Sep 2006	B2
7115141	Menz et al.	Oct 2006	B2
7141064	Scott et al.	Nov 2006	B2
7175656	Khairkhahan	Feb 2007	B2
7198646	Figulla et al.	Apr 2007	B2
7201772	Schwammenthal et al.	Apr 2007	B2
7247134	Vidlund et al.	Jul 2007	B2
7252682	Seguin	Aug 2007	B2
7267686	DiMatteo et al.	Sep 2007	B2
7275604	Wall	Oct 2007	B1
7276078	Spenser et al.	Oct 2007	B2
7276084	Yang et al.	Oct 2007	B2
7316706	Bloom et al.	Jan 2008	B2
7318278	Zhang et al.	Jan 2008	B2
7326236	Andreas et al.	Feb 2008	B2
7329278	Seguin et al.	Feb 2008	B2
7331991	Kheradvar et al.	Feb 2008	B2
7335213	Hyde et al.	Feb 2008	B1
7374571	Pease et al.	May 2008	B2
7377941	Rhee et al.	May 2008	B2
7381210	Zarbatany et al.	Jun 2008	B2
7381218	Schreck	Jun 2008	B2
7393360	Spenser et al.	Jul 2008	B2
7404824	Webler et al.	Jul 2008	B1
7416554	Lam et al.	Aug 2008	B2
7422072	Dade	Sep 2008	B2
7429269	Schwammenthal et al.	Sep 2008	B2
7442204	Schwammenthal et al.	Oct 2008	B2
7445631	Salahieh et al.	Nov 2008	B2
7462191	Spenser et al.	Dec 2008	B2
7470285	Nugent et al.	Dec 2008	B2
7500989	Solem et al.	Mar 2009	B2
7503931	Kowalsky et al.	Mar 2009	B2
7510572	Gabbay	Mar 2009	B2
7510575	Spenser et al.	Mar 2009	B2
7513908	Lattouf	Apr 2009	B2
7524330	Berreklouw	Apr 2009	B2
7527647	Spence	May 2009	B2
7534260	Lattouf	May 2009	B2
7556646	Yang et al.	Jul 2009	B2
7579381	Dove	Aug 2009	B2
7585321	Cribier	Sep 2009	B2
7591847	Navia et al.	Sep 2009	B2
7618446	Andersen et al.	Nov 2009	B2
7618447	Case et al.	Nov 2009	B2
7621948	Herrmann et al.	Nov 2009	B2
7632304	Park	Dec 2009	B2
7632308	Loulmet	Dec 2009	B2
7635386	Gammie	Dec 2009	B1
7674222	Nikolic et al.	Mar 2010	B2
7674286	Alfieri et al.	Mar 2010	B2
7695510	Bloom et al.	Apr 2010	B2
7708775	Rowe et al.	May 2010	B2
7748389	Salahieh et al.	Jul 2010	B2
7766961	Patel et al.	Aug 2010	B2
7789909	Andersen et al.	Sep 2010	B2
7803168	Gifford et al.	Sep 2010	B2
7803184	McGuckin, Jr. et al.	Sep 2010	B2
7803185	Gabbay	Sep 2010	B2
7806928	Rowe et al.	Oct 2010	B2
7837727	Goetz et al.	Nov 2010	B2
7854762	Speziali et al.	Dec 2010	B2
7892281	Seguin et al.	Feb 2011	B2
7896915	Guyenot et al.	Mar 2011	B2
7901454	Kapadia et al.	Mar 2011	B2
7927370	Webler et al.	Apr 2011	B2
7931630	Nishtala et al.	Apr 2011	B2
7942928	Webler et al.	May 2011	B2
7955247	Levine et al.	Jun 2011	B2
7955385	Crittenden	Jun 2011	B2
7972378	Tabor et al.	Jul 2011	B2
7988727	Santamore et al.	Aug 2011	B2
7993394	Hariton et al.	Aug 2011	B2
8007992	Tian et al.	Aug 2011	B2
8029556	Rowe	Oct 2011	B2
8043368	Crabtree	Oct 2011	B2
8052749	Salahieh et al.	Nov 2011	B2
8052750	Tuval et al.	Nov 2011	B2
8052751	Aklog et al.	Nov 2011	B2
8062355	Figulla et al.	Nov 2011	B2
8062359	Marquez et al.	Nov 2011	B2
8070802	Lamphere et al.	Dec 2011	B2
8109996	Stacchino et al.	Feb 2012	B2
8142495	Hasenkam et al.	Mar 2012	B2
8152821	Gambale et al.	Apr 2012	B2
8157810	Case et al.	Apr 2012	B2
8167932	Bourang et al.	May 2012	B2
8167934	Styrc et al.	May 2012	B2
8187299	Goldfarb et al.	May 2012	B2
8206439	Gomez Duran	Jun 2012	B2
8216301	Bonhoeffer et al.	Jul 2012	B2
8226711	Mortier et al.	Jul 2012	B2
8236045	Benichou et al.	Aug 2012	B2
8241274	Keogh et al.	Aug 2012	B2
8252051	Chau et al.	Aug 2012	B2
8303653	Bonhoeffer et al.	Nov 2012	B2
8308796	Lashinski et al.	Nov 2012	B2
8323334	Deem et al.	Dec 2012	B2
8353955	Styrc et al.	Jan 2013	B2
RE44075	Williamson et al.	Mar 2013	E
8449599	Chau et al.	May 2013	B2
8454656	Tuval	Jun 2013	B2
8470028	Thornton et al.	Jun 2013	B2
8480730	Maurer et al.	Jul 2013	B2
8486138	Vesely	Jul 2013	B2
8506623	Wilson et al.	Aug 2013	B2
8506624	Vidlund et al.	Aug 2013	B2
8578705	Sindano et al.	Nov 2013	B2
8579913	Nielsen	Nov 2013	B2
8579963	Tabor	Nov 2013	B2
8591573	Barone	Nov 2013	B2
8591576	Hasenkam et al.	Nov 2013	B2
8597347	Maurer et al.	Dec 2013	B2
8685086	Navia et al.	Apr 2014	B2
8790394	Miller et al.	Jul 2014	B2
8845717	Khairkhahan et al.	Sep 2014	B2
8888843	Khairkhahan et al.	Nov 2014	B2
8900214	Nance et al.	Dec 2014	B2
8900295	Migliazza et al.	Dec 2014	B2
8926696	Cabiri et al.	Jan 2015	B2
8932342	McHugo et al.	Jan 2015	B2
8932348	Solem et al.	Jan 2015	B2
8945208	Jimenez et al.	Feb 2015	B2
8956407	Macoviak et al.	Feb 2015	B2
8979922	Jayasinghe et al.	Mar 2015	B2
8986376	Solem	Mar 2015	B2
9011522	Annest	Apr 2015	B2
9023099	Duffy et al.	May 2015	B2
9034032	McLean et al.	May 2015	B2
9034033	McLean et al.	May 2015	B2
9039757	McLean et al.	May 2015	B2
9039759	Alkhatib et al.	May 2015	B2
9078749	Lutter et al.	Jul 2015	B2
9084676	Chau et al.	Jul 2015	B2
9095433	Lutter et al.	Aug 2015	B2
9125742	Yoganathan et al.	Sep 2015	B2
9149357	Seguin	Oct 2015	B2
9161837	Kapadia	Oct 2015	B2
9168137	Subramanian et al.	Oct 2015	B2
9232998	Wilson et al.	Jan 2016	B2
9232999	Maurer et al.	Jan 2016	B2
9241702	Maisano et al.	Jan 2016	B2
9254192	Lutter et al.	Feb 2016	B2
9265608	Miller et al.	Feb 2016	B2
9289295	Aklog et al.	Mar 2016	B2
9289297	Wilson et al.	Mar 2016	B2
9345573	Nyuli et al.	May 2016	B2
9364325	Alon et al.	Jun 2016	B2
9480557	Pellegrini et al.	Nov 2016	B2
9480559	Vidlund et al.	Nov 2016	B2
9526611	Tegels et al.	Dec 2016	B2
9597181	Christianson et al.	Mar 2017	B2
9610159	Christianson et al.	Apr 2017	B2
9675454	Vidlund et al.	Jun 2017	B2
9730792	Lutter et al.	Aug 2017	B2
10667905	Ekvall	Jun 2020	B2
20010018611	Solem et al.	Aug 2001	A1
20010021872	Bailey et al.	Sep 2001	A1
20010025171	Mortier et al.	Sep 2001	A1
20020010427	Scarfone et al.	Jan 2002	A1
20020116054	Lundell et al.	Aug 2002	A1
20020139056	Finnell	Oct 2002	A1
20020151961	Lashinski et al.	Oct 2002	A1
20020161377	Rabkin	Oct 2002	A1
20020173842	Buchanan	Nov 2002	A1
20030010509	Hoffman	Jan 2003	A1
20030036698	Kohler et al.	Feb 2003	A1
20030050694	Yang et al.	Mar 2003	A1
20030078652	Sutherland	Apr 2003	A1
20030100939	Yodat et al.	May 2003	A1
20030105519	Fasol et al.	Jun 2003	A1
20030105520	Alferness et al.	Jun 2003	A1
20030120340	Liska et al.	Jun 2003	A1
20030130731	Vidlund et al.	Jul 2003	A1
20030149476	Damm et al.	Aug 2003	A1
20030212454	Scott et al.	Nov 2003	A1
20040039436	Spenser et al.	Feb 2004	A1
20040049266	Anduiza et al.	Mar 2004	A1
20040064014	Melvin et al.	Apr 2004	A1
20040092858	Wilson et al.	May 2004	A1
20040093075	Kuehne	May 2004	A1
20040097865	Anderson et al.	May 2004	A1
20040127983	Mortier et al.	Jul 2004	A1
20040133263	Dusbabek et al.	Jul 2004	A1
20040147958	Lam et al.	Jul 2004	A1
20040152947	Schroeder et al.	Aug 2004	A1
20040162610	Liska et al.	Aug 2004	A1
20040163828	Silverstein et al.	Aug 2004	A1
20040181239	Dorn et al.	Sep 2004	A1
20040186565	Schreck	Sep 2004	A1
20040186566	Hindrichs et al.	Sep 2004	A1
20040260317	Bloom et al.	Dec 2004	A1
20040260389	Case et al.	Dec 2004	A1
20050004652	van der Burg et al.	Jan 2005	A1
20050004666	Altieri et al.	Jan 2005	A1
20050075727	Wheatley	Apr 2005	A1
20050080402	Santamore et al.	Apr 2005	A1
20050096498	Houser et al.	May 2005	A1
20050107661	Lau et al.	May 2005	A1
20050113798	Slater et al.	May 2005	A1
20050113810	Houser et al.	May 2005	A1
20050113811	Houser et al.	May 2005	A1
20050119519	Girard et al.	Jun 2005	A9
20050121206	Dolan	Jun 2005	A1
20050125012	Houser et al.	Jun 2005	A1
20050137688	Salahieh et al.	Jun 2005	A1
20050137695	Salahieh et al.	Jun 2005	A1
20050137698	Salahieh et al.	Jun 2005	A1
20050148815	Mortier et al.	Jul 2005	A1
20050177180	Kaganov et al.	Aug 2005	A1
20050197695	Stacchino et al.	Sep 2005	A1
20050203614	Forster et al.	Sep 2005	A1
20050203615	Forster et al.	Sep 2005	A1
20050203617	Forster et al.	Sep 2005	A1
20050234546	Nugent et al.	Oct 2005	A1
20050240200	Bergheim	Oct 2005	A1
20050251209	Saadat et al.	Nov 2005	A1
20050256567	Lim et al.	Nov 2005	A1
20050288763	Andreas et al.	Dec 2005	A1
20050288766	Plain et al.	Dec 2005	A1
20060004442	Spenser et al.	Jan 2006	A1
20060025784	Starksen et al.	Feb 2006	A1
20060025857	Bergheim et al.	Feb 2006	A1
20060030885	Hyde	Feb 2006	A1
20060042803	Gallaher	Mar 2006	A1
20060047338	Jenson et al.	Mar 2006	A1
20060052868	Mortier et al.	Mar 2006	A1
20060058872	Salahieh et al.	Mar 2006	A1
20060094983	Burbank et al.	May 2006	A1
20060129025	Levine et al.	Jun 2006	A1
20060142784	Kontos	Jun 2006	A1
20060161040	McCarthy et al.	Jul 2006	A1
20060161249	Realyvasquez et al.	Jul 2006	A1
20060167541	Lattouf	Jul 2006	A1
20060195134	Crittenden	Aug 2006	A1
20060195183	Navia et al.	Aug 2006	A1
20060229708	Powell et al.	Oct 2006	A1
20060229719	Marquez et al.	Oct 2006	A1
20060241745	Solem	Oct 2006	A1
20060247491	Vidlund et al.	Nov 2006	A1
20060259135	Navia et al.	Nov 2006	A1
20060259136	Nguyen et al.	Nov 2006	A1
20060259137	Artof et al.	Nov 2006	A1
20060276874	Wilson et al.	Dec 2006	A1
20060282161	Huynh et al.	Dec 2006	A1
20060287716	Banbury et al.	Dec 2006	A1
20060287717	Rowe et al.	Dec 2006	A1
20070005131	Taylor	Jan 2007	A1
20070005231	Seguchi	Jan 2007	A1
20070010877	Salahieh et al.	Jan 2007	A1
20070016286	Herrmann et al.	Jan 2007	A1
20070016288	Gurskis et al.	Jan 2007	A1
20070027535	Purdy et al.	Feb 2007	A1
20070038291	Case et al.	Feb 2007	A1
20070050020	Spence	Mar 2007	A1
20070061010	Hauser et al.	Mar 2007	A1
20070066863	Rafiee et al.	Mar 2007	A1
20070073387	Forster et al.	Mar 2007	A1
20070078297	Rafiee et al.	Apr 2007	A1
20070083076	Lichtenstein	Apr 2007	A1
20070083259	Bloom et al.	Apr 2007	A1
20070088431	Bourang et al.	Apr 2007	A1
20070093890	Eliasen et al.	Apr 2007	A1
20070100439	Cangialosi et al.	May 2007	A1
20070112422	Dehdashtian	May 2007	A1
20070112425	Schaller et al.	May 2007	A1
20070118151	Davidson	May 2007	A1
20070118154	Crabtree	May 2007	A1
20070118210	Pinchuk	May 2007	A1
20070118213	Loulmet	May 2007	A1
20070142906	Figulla et al.	Jun 2007	A1
20070161846	Nikolic et al.	Jul 2007	A1
20070162103	Case et al.	Jul 2007	A1
20070168024	Khairkhahan	Jul 2007	A1
20070185565	Schwammenthal et al.	Aug 2007	A1
20070185571	Kapadia et al.	Aug 2007	A1
20070203575	Forster et al.	Aug 2007	A1
20070213813	Von Segesser et al.	Sep 2007	A1
20070215362	Rodgers	Sep 2007	A1
20070221388	Johnson	Sep 2007	A1
20070233239	Navia et al.	Oct 2007	A1
20070239265	Birdsall	Oct 2007	A1
20070256843	Pahila	Nov 2007	A1
20070265658	Nelson et al.	Nov 2007	A1
20070267202	Mariller	Nov 2007	A1
20070270932	Headley et al.	Nov 2007	A1
20070270943	Solem et al.	Nov 2007	A1
20070293944	Spenser et al.	Dec 2007	A1
20080009940	Cribier	Jan 2008	A1
20080065011	Marchand et al.	Mar 2008	A1
20080071361	Tuval et al.	Mar 2008	A1
20080071362	Tuval et al.	Mar 2008	A1
20080071363	Tuval et al.	Mar 2008	A1
20080071366	Tuval et al.	Mar 2008	A1
20080071368	Tuval et al.	Mar 2008	A1
20080071369	Tuval et al.	Mar 2008	A1
20080082163	Woo	Apr 2008	A1
20080082166	Styrc et al.	Apr 2008	A1
20080091264	Machold et al.	Apr 2008	A1
20080114442	Mitchell et al.	May 2008	A1
20080125861	Webler et al.	May 2008	A1
20080147179	Cai et al.	Jun 2008	A1
20080154355	Benichou et al.	Jun 2008	A1
20080154356	Obermiller et al.	Jun 2008	A1
20080161911	Revuelta et al.	Jul 2008	A1
20080172035	Starksen et al.	Jul 2008	A1
20080177381	Navia et al.	Jul 2008	A1
20080183203	Fitzgerald et al.	Jul 2008	A1
20080188928	Salahieh et al.	Aug 2008	A1
20080208328	Antocci et al.	Aug 2008	A1
20080208332	Lamphere et al.	Aug 2008	A1
20080221672	Lamphere et al.	Sep 2008	A1
20080243150	Starksen et al.	Oct 2008	A1
20080243245	Fhambar et al.	Oct 2008	A1
20080255660	Guyenot et al.	Oct 2008	A1
20080255661	Straubinger et al.	Oct 2008	A1
20080281411	Berreklouw	Nov 2008	A1
20080288060	Kaye et al.	Nov 2008	A1
20080293996	Evans et al.	Nov 2008	A1
20090005863	Goetz et al.	Jan 2009	A1
20090048668	Wilson et al.	Feb 2009	A1
20090054968	Bonhoeffer et al.	Feb 2009	A1
20090054974	McGuckin, Jr. et al.	Feb 2009	A1
20090054976	Tuval et al.	Feb 2009	A1
20090062908	Bonhoeffer et al.	Mar 2009	A1
20090076598	Salahieh et al.	Mar 2009	A1
20090082619	De Marchena	Mar 2009	A1
20090088836	Bishop et al.	Apr 2009	A1
20090099410	De Marchena	Apr 2009	A1
20090112309	Jaramillo et al.	Apr 2009	A1
20090131849	Maurer et al.	May 2009	A1
20090132035	Roth et al.	May 2009	A1
20090137861	Goldberg et al.	May 2009	A1
20090138079	Tuval et al.	May 2009	A1
20090157175	Benichou	Jun 2009	A1
20090164005	Dove et al.	Jun 2009	A1
20090171432	Von Segesser et al.	Jul 2009	A1
20090171447	Von Segesser et al.	Jul 2009	A1
20090171456	Kveen et al.	Jul 2009	A1
20090177266	Powell et al.	Jul 2009	A1
20090192601	Rafiee et al.	Jul 2009	A1
20090210052	Forster et al.	Aug 2009	A1
20090216322	Le et al.	Aug 2009	A1
20090222076	Figulla et al.	Sep 2009	A1
20090224529	Gill	Sep 2009	A1
20090234318	Loulmet et al.	Sep 2009	A1
20090234435	Johnson et al.	Sep 2009	A1
20090234443	Ottma et al.	Sep 2009	A1
20090240320	Tuval et al.	Sep 2009	A1
20090248149	Gabbay	Oct 2009	A1
20090276040	Rowe et al.	Nov 2009	A1
20090281619	Le et al.	Nov 2009	A1
20090287299	Tabor et al.	Nov 2009	A1
20090319037	Rowe et al.	Dec 2009	A1
20090326575	Galdonik et al.	Dec 2009	A1
20100016958	St. Goar et al.	Jan 2010	A1
20100021382	Dorshow et al.	Jan 2010	A1
20100023117	Yoganathan et al.	Jan 2010	A1
20100036479	Hill et al.	Feb 2010	A1
20100049313	Alon et al.	Feb 2010	A1
20100082094	Quadri et al.	Apr 2010	A1
20100161041	Maisano et al.	Jun 2010	A1
20100168839	Braido et al.	Jul 2010	A1
20100179641	Ryan et al.	Jul 2010	A1
20100185277	Braido et al.	Jul 2010	A1
20100185278	Schankereli	Jul 2010	A1
20100191326	Alkhatib	Jul 2010	A1
20100192402	Yamaguchi et al.	Aug 2010	A1
20100204781	Alkhatib	Aug 2010	A1
20100210899	Schankereli	Aug 2010	A1
20100217382	Chau et al.	Aug 2010	A1
20100234940	Dolan	Sep 2010	A1
20100249489	Jarvik	Sep 2010	A1
20100249923	Alkhatib et al.	Sep 2010	A1
20100262157	Silver	Oct 2010	A1
20100280604	Zipory et al.	Nov 2010	A1
20100286768	Alkhatib	Nov 2010	A1
20100298755	McNamara et al.	Nov 2010	A1
20100298931	Quadri et al.	Nov 2010	A1
20110004296	Lutter et al.	Jan 2011	A1
20110015616	Straubinger et al.	Jan 2011	A1
20110015728	Jimenez et al.	Jan 2011	A1
20110015729	Jimenez et al.	Jan 2011	A1
20110029072	Gabbay	Feb 2011	A1
20110046712	Melsheimer et al.	Feb 2011	A1
20110066231	Cartledge et al.	Mar 2011	A1
20110112632	Chau et al.	May 2011	A1
20110137397	Chau et al.	Jun 2011	A1
20110137408	Bergheim	Jun 2011	A1
20110224655	Asirvatham et al.	Sep 2011	A1
20110224678	Gabbay	Sep 2011	A1
20110224728	Martin et al.	Sep 2011	A1
20110224784	Quinn	Sep 2011	A1
20110245911	Quill et al.	Oct 2011	A1
20110251682	Murray, III et al.	Oct 2011	A1
20110264206	Tabor	Oct 2011	A1
20110288637	De Marchena	Nov 2011	A1
20110319988	Schankereli et al.	Dec 2011	A1
20110319989	Lane et al.	Dec 2011	A1
20120010694	Lutter et al.	Jan 2012	A1
20120016468	Robin et al.	Jan 2012	A1
20120022640	Gross et al.	Jan 2012	A1
20120035703	Lutter et al.	Feb 2012	A1
20120035713	Lutter et al.	Feb 2012	A1
20120035722	Tuval	Feb 2012	A1
20120059487	Cunanan et al.	Mar 2012	A1
20120083874	Dale et al.	Apr 2012	A1
20120089171	Hastings et al.	Apr 2012	A1
20120101571	Thambar et al.	Apr 2012	A1
20120101572	Kovalsky et al.	Apr 2012	A1
20120116351	Chomas et al.	May 2012	A1
20120123529	Levi et al.	May 2012	A1
20120165930	Gifford, III et al.	Jun 2012	A1
20120179244	Schankereli et al.	Jul 2012	A1
20120203336	Annest	Aug 2012	A1
20120215303	Quadri et al.	Aug 2012	A1
20120239142	Liu et al.	Sep 2012	A1
20120283824	Lutter et al.	Nov 2012	A1
20130030522	Rowe et al.	Jan 2013	A1
20130053950	Rowe et al.	Feb 2013	A1
20130059747	Mann et al.	Mar 2013	A1
20130066341	Ketai et al.	Mar 2013	A1
20130079873	Migliazza et al.	Mar 2013	A1
20130131788	Quadri et al.	May 2013	A1
20130172978	Vidlund et al.	Jul 2013	A1
20130184811	Rowe et al.	Jul 2013	A1
20130190860	Sundt, III	Jul 2013	A1
20130190861	Chau et al.	Jul 2013	A1
20130197622	Mitra et al.	Aug 2013	A1
20130226288	Goldwasser et al.	Aug 2013	A1
20130231735	Deem et al.	Sep 2013	A1
20130268064	Duffy	Oct 2013	A1
20130274874	Hammer	Oct 2013	A1
20130282101	Eidenschink et al.	Oct 2013	A1
20130310928	Morriss et al.	Nov 2013	A1
20130317603	McLean et al.	Nov 2013	A1
20130325041	Annest et al.	Dec 2013	A1
20130325110	Khalil et al.	Dec 2013	A1
20130338752	Geusen et al.	Dec 2013	A1
20140005767	Glazier et al.	Jan 2014	A1
20140081323	Hawkins	Mar 2014	A1
20140094918	Vishnubholta et al.	Apr 2014	A1
20140128963	Quill	May 2014	A1
20140142691	Pouletty	May 2014	A1
20140163668	Rafiee	Jun 2014	A1
20140194981	Menk et al.	Jul 2014	A1
20140214159	Vidlund et al.	Jul 2014	A1
20140222142	Kovalsky et al.	Aug 2014	A1
20140243966	Garde et al.	Aug 2014	A1
20140277419	Garde et al.	Sep 2014	A1
20140296969	Tegels et al.	Oct 2014	A1
20140296970	Ekvall et al.	Oct 2014	A1
20140296971	Tegels et al.	Oct 2014	A1
20140296972	Tegels et al.	Oct 2014	A1
20140296975	Tegels et al.	Oct 2014	A1
20140303718	Tegels et al.	Oct 2014	A1
20140309732	Solem	Oct 2014	A1
20140316516	Vidlund et al.	Oct 2014	A1
20140316518	Kheradvar et al.	Oct 2014	A1
20140324160	Benichou et al.	Oct 2014	A1
20140324161	Tegels et al.	Oct 2014	A1
20140324164	Gross et al.	Oct 2014	A1
20140358224	Tegels et al.	Dec 2014	A1
20140364944	Lutter et al.	Dec 2014	A1
20140379076	Vidlund et al.	Dec 2014	A1
20150005874	Vidlund et al.	Jan 2015	A1
20150011821	Gorman et al.	Jan 2015	A1
20150025553	Del Nido et al.	Jan 2015	A1
20150057705	Vidlund	Feb 2015	A1
20150073542	Heldman	Mar 2015	A1
20150073545	Braido	Mar 2015	A1
20150105856	Rowe et al.	Apr 2015	A1
20150112430	Creaven	Apr 2015	A1
20150119936	Gilmore et al.	Apr 2015	A1
20150119978	Tegels et al.	Apr 2015	A1
20150127096	Rowe et al.	May 2015	A1
20150142100	Morriss et al.	May 2015	A1
20150142101	Coleman et al.	May 2015	A1
20150142103	Vidlund	May 2015	A1
20150142104	Braido	May 2015	A1
20150173897	Raanani et al.	Jun 2015	A1
20150196393	Vidlund et al.	Jul 2015	A1
20150196688	James et al.	Jul 2015	A1
20150202044	Chau et al.	Jul 2015	A1
20150216653	Freudenthal	Aug 2015	A1
20150216660	Pintor et al.	Aug 2015	A1
20150223820	Olson et al.	Aug 2015	A1
20150223934	Vidlund et al.	Aug 2015	A1
20150238729	Jenson et al.	Aug 2015	A1
20150272731	Racchini et al.	Oct 2015	A1
20150305860	Wang et al.	Oct 2015	A1
20150305864	Quadri et al.	Oct 2015	A1
20150305867	Liu et al.	Oct 2015	A1
20150305868	Lutter et al.	Oct 2015	A1
20150327995	Morin et al.	Nov 2015	A1
20150328001	McLean et al.	Nov 2015	A1
20150335424	McLean et al.	Nov 2015	A1
20150335429	Morriss et al.	Nov 2015	A1
20150342717	O'Donnell et al.	Dec 2015	A1
20150351903	Morriss et al.	Dec 2015	A1
20150351906	Hammer et al.	Dec 2015	A1
20160008131	Christianson et al.	Jan 2016	A1
20160067042	Murad et al.	Mar 2016	A1
20160074160	Christianson et al.	Mar 2016	A1
20160106537	Christianson et al.	Apr 2016	A1
20160113764	Sheahan et al.	Apr 2016	A1
20160143736	Mdlund et al.	May 2016	A1
20160151155	Lutter et al.	Jun 2016	A1
20160206280	Vidlund et al.	Jul 2016	A1
20160242902	Morriss et al.	Aug 2016	A1
20160262879	Meiri et al.	Sep 2016	A1
20160262881	Schankereli et al.	Sep 2016	A1
20160317290	Chau et al.	Nov 2016	A1
20160324635	Vidlund et al.	Nov 2016	A1
20160331527	Vidlund et al.	Nov 2016	A1
20160346086	Solem	Dec 2016	A1
20160367365	Conklin	Dec 2016	A1
20160367367	Maisano et al.	Dec 2016	A1
20160367368	Vidlund et al.	Dec 2016	A1
20170079790	Vidlund et al.	Mar 2017	A1
20170128208	Christianson et al.	May 2017	A1
20170181854	Christianson et al.	Jun 2017	A1
20170196688	Christianson et al.	Jul 2017	A1
20170252153	Chau et al.	Sep 2017	A1
20170266001	Vidlund et al.	Sep 2017	A1
20210220135	Kovalsky	Jul 2021	A1

Foreign Referenced Citations (131)

Number	Date	Country
1486161	Mar 2004	CN
1961845	May 2007	CN
2902226	May 2007	CN
101146484	Mar 2008	CN
101180010	May 2008	CN
101180010	Dec 2010	CN
101984938	Mar 2011	CN
102639179	Aug 2012	CN
102869317	Jan 2013	CN
102869318	Jan 2013	CN
102869321	Jan 2013	CN
103220993	Jul 2013	CN
2246526	Mar 1973	DE
19532846	Mar 1997	DE
19546692	Jun 1997	DE
19857887	Jul 2000	DE
19907646	Aug 2000	DE
10049812	Apr 2002	DE
10049813	Apr 2002	DE
10049815	Apr 2002	DE
102006052564	Dec 2007	DE
102006052710	May 2008	DE
102007043831	Apr 2009	DE
0103546	Mar 1984	EP
1057460	Dec 2000	EP
1088529	Apr 2001	EP
1469797	Oct 2004	EP
1469797	Nov 2005	EP
2111800	Oct 2009	EP
2193762	Jun 2010	EP
2278944	Feb 2011	EP
2747707	Jul 2014	EP
2918248	Sep 2015	EP
2788217	Jul 2000	FR
2815844	May 2002	FR
2003505146	Feb 2003	JP
2008504078	Feb 2008	JP
2009511229	Mar 2009	JP
2009514628	Apr 2009	JP
2013525039	Jun 2013	JP
2013538086	Oct 2013	JP
2014513585	Jun 2014	JP
1017275	Aug 2002	NL
1271508	Nov 1986	SU
9217118	Oct 1992	WO
9301768	Feb 1993	WO
9829057	Jul 1998	WO
9940964	Aug 1999	WO
9947075	Sep 1999	WO
2000018333	Apr 2000	WO
2000030550	Jun 2000	WO
200041652	Jul 2000	WO
200047139	Aug 2000	WO
2001035878	May 2001	WO
2001049213	Jul 2001	WO
0154625	Aug 2001	WO
2001054624	Aug 2001	WO
2001056512	Aug 2001	WO
2001061289	Aug 2001	WO
0176510	Oct 2001	WO
200176510	Oct 2001	WO
0182840	Nov 2001	WO
2001082840	Nov 2001	WO
2002004757	Jan 2002	WO
0222054	Mar 2002	WO
2002022054	Mar 2002	WO
2002028321	Apr 2002	WO
0236048	May 2002	WO
2002041789	May 2002	WO
0243620	Jun 2002	WO
0249540	Jun 2002	WO
2002043620	Jun 2002	WO
2002049540	Jun 2002	WO
2002076348	Oct 2002	WO
2003003943	Jan 2003	WO
2003030776	Apr 2003	WO
03047468	Jun 2003	WO
2003049619	Jun 2003	WO
2004019825	Mar 2004	WO
2005102181	Nov 2005	WO
2006005082	Jan 2006	WO
2006014233	Feb 2006	WO
2006034008	Mar 2006	WO
2006070372	Jul 2006	WO
2006113906	Oct 2006	WO
2006127756	Nov 2006	WO
2007081412	Jul 2007	WO
2008005405	Jan 2008	WO
2008035337	Mar 2008	WO
2008091515	Jul 2008	WO
2008125906	Oct 2008	WO
2008147964	Dec 2008	WO
2009024859	Feb 2009	WO
2009026563	Feb 2009	WO
2009045338	Apr 2009	WO
2009094500	Jul 2009	WO
2009132187	Oct 2009	WO
2010022138	Feb 2010	WO
2010090878	Aug 2010	WO
2010098857	Sep 2010	WO
2010121076	Oct 2010	WO
2011017440	Feb 2011	WO
2011022658	Feb 2011	WO
2011069048	Jun 2011	WO
2011072084	Jun 2011	WO
2011106735	Sep 2011	WO
2011109813	Sep 2011	WO
2011159342	Dec 2011	WO
2011163275	Dec 2011	WO
2012027487	Mar 2012	WO
2012036742	Mar 2012	WO
2012177942	Dec 2012	WO
2013045262	Apr 2013	WO
2013096411	Jun 2013	WO
2013175468	Nov 2013	WO
2014071077	May 2014	WO
2014121280	Aug 2014	WO
2014144247	Sep 2014	WO
2014144937	Sep 2014	WO
2014162306	Oct 2014	WO
2014189974	Nov 2014	WO
2015051430	Apr 2015	WO
2015058039	Apr 2015	WO
2015063580	May 2015	WO
2015065646	May 2015	WO
2015120122	Aug 2015	WO
2015138306	Sep 2015	WO
2016112085	Jul 2016	WO
2016126942	Aug 2016	WO
2016168609	Oct 2016	WO
2016196933	Dec 2016	WO

Non-Patent Literature Citations (54)

Entry
US 9,155,620 B2, 10/2015, Gross et al. (withdrawn)
Bernacca, G. M. et al., “Polyurethane heart valves: Fatigue failure, calcification, and polyurethane structure,” Journal of Biomedical Materials Research, Mar. 5, 1997, 34(3):371-379.
Drawbaugh, K , “Feature—Heart Surgeons Explore Minimally Invasive Methods,” Reuters Limited, Jul. 16, 1996, 3 pages.
Henning Rud Andersen, “Transluminal Catheter Implanted Prosthetic Heart Valves,” International Journal of Angiology, 1998, Issue 2, vol. 7 pp. 102-106.
Ma L., et al., Double-crowned valved stents for off-pump mitral valve replacement. Eur J Cardiothorac Surg. Aug. 200528(2): 194-198.
Moazami, N et al., “Transluminal aortic valve placement: A feasibility study with a newly designed collapsible aortic valve,” ASAIO Journal, Sep./ Oct. 1996 42(5):M381-M385.
Rosch, J. et al., “The Birth, Early Years and Future of Interventional Radiology,” J Vase Interv Radiol., Jul. 2003, 4:841-853.
US 9,155,620, Oct. 2015, Gross et al. (withdrawn)
Extended European Search Report including Written Opinion for Application No. EP20168419.8, dated Jul. 21, 2020, pp. 1-8.
Al Zaibag, Muayed, et al., “Percutaneous Balloon Valvotomy in Tricuspid Stenos's,” British Heart Journal, Jan. 1987, vol. 57, No. 1, pp. 51-53.
Al-Khaja, N. et al., “Eleven Years' Experience with Carpentier-Edwards Biological Valves in Relation to Survival and Complications,” European Journal of Cardiothoracic Surgery, Jun. 30, 1989, 3:305-311.
Almagor, Y. et al., “Balloon Expandable Stent Implantation in Stenotic Right Heart Valved Conduits,” Journal of the American College of Cardiology, Nov. 1, 1990, 16(6):1310-1314.
H. R. Andersen et al., “Transluminal Implantation of Artificial Heart Valves: Description of a New Expandable Aortic Valve and Initial Results with Implantation by Catheter Technique in Closed Chest Pigs,” European Heart Journal, 1992, Issue 5, vol. 13, pp. 704-708.
Andersen, H. R., “History of Percutaneous Aortic Valve Prosthesis,” Herz, Aug. 2009, 34(5):343-346.
Andersen, H. R., “Transluminal catheter implanted prosthetic heart valves,” International Journal of Angiology, 1998, 7(2):102-106.
Robert C. Ashton Jr., “Development of an Intraluminal Device for the Treatment of Aortic Regurgitation: Prototype and in Vitro Testing System,” Journal of Thoracic and Cardiovascular Surgery, 1996, Issue/vol. 112, pp. 979-983.
Benchimol, A. et al., “Simultaneous Left Ventricular Echocardiography and Aortic Blood Velocity During Rapid Right Ventricular Pacing in Man,” The American Journal of the Medical Sciences, Jan.-Feb. 1977, 273(1):55-62.
G. M. Bernacca, et al., “Polyurethane Heart Valves: Fatigue Failure, Calcification, and Polyurethane Structure,” Journal of Biomedical Materials Research, Mar. 5, 1997, Issue 3, vol. 34, pp. 371-379.
Boudjemline, Y. et al., “Steps Toward the Percutaneous Replacement of Atrioventricular Valves: An Experimental Study,” Journal of the American College of Cardiology, Jul. 2005, 46(2):360-365.
Buckberg, G. et al., “Restoring Papillary Muscle Dimensions During Restoration In Dilated Hearts,” Interactive Cardiovascular and Thoracic Surgery, 2005, 4:475-477.
Chamberlain, G., “Ceramics Replace Body Parts,” Design News, Jun. 9, 1997, Issue 11, vol. 52, 5 pages.
Choo, S. J. et al., “Aortic Root Geometry: Pattern of Differences Between Leaflets and Sinuses of Valsava,” The Journal of Heart Valve Disease, Jul. 1999, 8:407-415.
Declaration of Malcolm J. R. Dalrymple-Hay, Nov. 9, 2012, pp. 1-11; with Curriculum Vitae, Oct. 4, 2012.
Dotter, C. T. et al., “Transluminal Treatment of Arteriosclerotic Obstruction. Description of a New Technic and a Preliminary Report of its Application,” Circulation, Nov. 1964, 30:654-670.
Gray, H., The Aorta, Anatomy of the Human Body, 1918, Retrieved from the Internet <http://www.bartleby.com/107/142.html>, Dec. 10, 2012, 5 pages.
Gray, H., The Heart, Anatomy of the Human Body, 1918, Retrieved from the Internet <http://education.yahoo.com/reference/gray/subjects/subject/138>, Aug. 10, 2012, 9 pages.
Greenhalgh, E. S., “Design and characterization of a biomimetic prosthetic aortic heart valve,” 1994, ProQuest Dissertations and Theses, Department of Fiber and Polymer Science, North Carolina State University at Raleigh, 159 pages.
Inoue, K. et al., “Clinical Application of Transvenous Mitral Commissurotomy by a New Balloon Catheter,” The Journal of Thoracic and Cardiovascular Surgery, 1984, 87:394-402.
Jin, X. Y. et al., “Aortic Root Geometry and Stentless Porcine Valve Competence,” Seminars in Thoracic and Cardiovascular Surgery, Oct. 1999, 11(4):145-150.
Knudsen, L. L. et al., “Catheter-implanted prosthetic heart valves. Transluminal catheter implantation of a new expandable artificial heart valve in the descending thoracic aorta in isolated vessels and closed chest pigs,” The International Journal of Artificial Organs, 1993, 16(5):253-262.
Kolata, G., “Device That Opens Clogged Arteries Gets a Failing Grade in a New Study,” New York Times [online], <http://www.nytimes.com/1991/01/03/health/device-that-opens-clogged-ar-teries-gets-a-faili . . . ,>, published Jan. 3, 1991,retrieved from the Internet on Feb. 5, 2016, 3 pages.
Lawrence, D. D., “Percutaneous Endovascular Graft: Experimental Evaluation,” Radiology, 1987, 163:357-360.
Lozonschi, L., et al. “Transapical mitral valved stent implantation: A survival series in swine,” The Journal of Thoracic and Cardiovascular Surgery, 140(2):422-426 (Aug. 2010) published online Mar. 12, 2010, 1 page.
Lutter, Georg, et al., Mitral valved stent implantation, European Journal of Cardio-Thoracic Surgery, 2010, vol. 38, pp. 350-355.
Ma, L. et al., “Double-crowned valved stents for off-pump mitral valve replacement,” European Journal of Cardio-Thoracic Surgery, Aug. 2005, 28(2): 194-198.
Orton, C., “Mitralseal: Hybrid Transcatheter Mitral Valve Replacement,” Symposium: Small Animal Proceedings, 2011, pp. 311-312.
Pavcnik, D. et al. “Development and Initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement,” Radiology, 1992; 183:151-154.
Porstmann, W. et al., “Der Verschluβ des Ductus Arteriosus Persistens ohne Thorakotomie,” Thoraxchirurgie Vaskuläre Chirurgie, Band 15, Heft 2, Stuttgart, Apr. 1967, pp. 199-203.
Rashkind, W. J., “Creation of an Atrial Septal Defect Without Thoracotomy,” The Journal of the American Medical Association, Jun. 13, 1966, 196( 11 ): 173-174.
Rashkind, W. J., “Historical Aspects of Interventional Cardiology: Past, Present, Future,” Texas Heart Institute Journal, Dec. 1986, 13(4):363-367.
Reul, H. et al., “The Geomety of the Aortic Root in Health, at Valve Disease and After Valve Replacement,” J. Biomechanics, 1990, 23(2):181-191.
Ross, D. N., “Aortic Valve Surgery,” Guy's Hospital, London, 1968, pp. 192-197.
Rousseau, E. P. M. et al., “A Mechanical Analysis of the Closed Hancock Heart Valve Prosthesis,” Journal of Biomechanics, 1998, 21(7):545-562.
Sabbah, A. N. et al., “Mechanical Factors in the Degeneration of Porcine Bioprosthetic Valves: An Overview,” Dec. 1989, Journal of Cardiac Surgery, 4(4):302-309.
Selby, M.D., J. Bayne, “Experience with New Retrieval Forceps for Foreign Body Removal in the Vascular, Urinary, and Biliary Systems,” Radiology 1990; 176:535-538.
Serruys, P.W., et al., “Stenting of Coronary Arteries. Are we the Sorcerer?s Apprentice?,” European Heart Journal (1989) 10, 774-782, pp. 37-45, Jun. 13, 1989.
Sigwart, U., “An Overview of Intravascular Stents: Old and New,” Chapter 48, Interventional Cardiology, 2nd Edition, W.B. Saunders Company, Philadelphia, PA, © 1994, 1990, pp. 803-815.
Tofeig, M. et al., “Transcatheter Closure of a Mid-Muscular Ventricular Septal Defect with an Amplatzer VSD Occluder Device,” Heart, 1999, 81:438-440.
Uchida, Barry T., et al., “Modifications of Gianturco Expandable Wire Stents,” AJR:150, May 1988, Dec. 3, 1987, pp. 1185-1187.
Watt, A.H., et al. “Intravenous Adenosine in the Treatment of Supraventricular Tachycardia; a Dose-Ranging Study and Interaction with Dipyridamole,” British Journal of Clinical Pharmacology (1986), 21, pp. 227-230.
Webb, J. G. et al., “Percutaneous Aortic Valve Implantation Retrograde from the Femoral Artery,” Circulation, 2006, 113:842-850.
Wheatley, M.D., David J., “Valve Prostheses,” Rob & Smith's Operative Surgery, Fourth Edition, pp. 415-424, ButtenNorths 1986.
Yoganathan, A. P. et al., “The Current Status of Prosthetic Heart Valves,” In Polymetric Materials and Artificial Organs, Mar. 20, 1983, pp. 111-150, American Chemical Society.
“Shape Memory Alloys,” Retrieved from the Internet: <http://webdocs.cs.ualberta.ca/˜database/MEMS/sma.html>, Feb. 5, 2016, 3 pages.

Related Publications (1)

	Number	Date	Country
	20200246143 A1	Aug 2020	US

Provisional Applications (2)

	Number	Date	Country
	62312136	Mar 2016	US
	62148579	Apr 2015	US

Divisions (1)

	Number	Date	Country
Parent	15730148	Oct 2017	US
Child	16856223		US

Continuations (1)

	Number	Date	Country
Parent	PCT/US2016/027770	Apr 2016	US
Child	15730148		US

Apparatus and methods for delivery, repositioning, and retrieval of transcatheter prosthetic valves

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

Field of Search

CPC

International Classifications

Term Extension

Abstract